KR20150103968A - Organic compounds and organic electro luminescence device comprising the same - Google Patents
Organic compounds and organic electro luminescence device comprising the same Download PDFInfo
- Publication number
- KR20150103968A KR20150103968A KR1020140025707A KR20140025707A KR20150103968A KR 20150103968 A KR20150103968 A KR 20150103968A KR 1020140025707 A KR1020140025707 A KR 1020140025707A KR 20140025707 A KR20140025707 A KR 20140025707A KR 20150103968 A KR20150103968 A KR 20150103968A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- aryl
- mmol
- compound
- alkyl
- Prior art date
Links
- YTTFZSLFNVFHAQ-UHFFFAOYSA-N Clc1nc(-c(cc2)ccc2-c2cccc3c2cccc3)c(cccc2)c2n1 Chemical compound Clc1nc(-c(cc2)ccc2-c2cccc3c2cccc3)c(cccc2)c2n1 YTTFZSLFNVFHAQ-UHFFFAOYSA-N 0.000 description 3
- 0 CC(CC(C(C)=*)=*)N Chemical compound CC(CC(C(C)=*)=*)N 0.000 description 2
- WAORTRBKRGDMPV-UHFFFAOYSA-N c(cc1)ccc1N1c(c2c(cc3)[nH]c4ccccc24)c3-c(cccc2)c2-c2ccccc12 Chemical compound c(cc1)ccc1N1c(c2c(cc3)[nH]c4ccccc24)c3-c(cccc2)c2-c2ccccc12 WAORTRBKRGDMPV-UHFFFAOYSA-N 0.000 description 2
- JLRDOAHVLXVODQ-UHFFFAOYSA-N c(cc1)ccc1N1c(ccc2c3c(cccc4)c4[nH]2)c3-c2ccccc2-c2ccccc12 Chemical compound c(cc1)ccc1N1c(ccc2c3c(cccc4)c4[nH]2)c3-c2ccccc2-c2ccccc12 JLRDOAHVLXVODQ-UHFFFAOYSA-N 0.000 description 2
- FWESVNIHRVSDDV-UHFFFAOYSA-N Brc(cc1)ccc1-c(cc1)cc2c1c1ccccc1c1ccccc21 Chemical compound Brc(cc1)ccc1-c(cc1)cc2c1c1ccccc1c1ccccc21 FWESVNIHRVSDDV-UHFFFAOYSA-N 0.000 description 1
- AYHGAQGOMUQMTR-UHFFFAOYSA-N Brc(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound Brc(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 AYHGAQGOMUQMTR-UHFFFAOYSA-N 0.000 description 1
- HNZUKQQNZRMNGS-UHFFFAOYSA-N Brc1cc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)ccc1 Chemical compound Brc1cc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)ccc1 HNZUKQQNZRMNGS-UHFFFAOYSA-N 0.000 description 1
- CRJISNQTZDMKQD-UHFFFAOYSA-N Brc1ccc2[o]c3ccccc3c2c1 Chemical compound Brc1ccc2[o]c3ccccc3c2c1 CRJISNQTZDMKQD-UHFFFAOYSA-N 0.000 description 1
- IGZGGJDFVURMOT-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c(cc2c(cc3)c4c5c3-c(cccc3)c3-c3ccccc3N5c3ccccc3)ccc2[n]4-c2nc(-c(cc3)ccc3-c3cccc4c3cccc4)c(cccc3)c3n2)cc(-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c1cc(-c(cc2c(cc3)c4c5c3-c(cccc3)c3-c3ccccc3N5c3ccccc3)ccc2[n]4-c2nc(-c(cc3)ccc3-c3cccc4c3cccc4)c(cccc3)c3n2)cc(-c2ccccc2)c1 IGZGGJDFVURMOT-UHFFFAOYSA-N 0.000 description 1
- PFRAELHQBCUJBJ-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-c(cc2)ccc2-[n](c2c3cccc2)c(cc2)c3c-3c2N(c2ccccc2)c2ccccc2-c2ccccc-32)nc(-c2ccccc2)n1 Chemical compound c(cc1)ccc1-c1nc(-c(cc2)ccc2-[n](c2c3cccc2)c(cc2)c3c-3c2N(c2ccccc2)c2ccccc2-c2ccccc-32)nc(-c2ccccc2)n1 PFRAELHQBCUJBJ-UHFFFAOYSA-N 0.000 description 1
- OLLZUKMBACPRLE-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2cccc(-[n]3c4ccc5N(c6ccccc6)c6ccccc6-c6ccccc6-c5c4c4c3cccc4)c2)n1 Chemical compound c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2cccc(-[n]3c4ccc5N(c6ccccc6)c6ccccc6-c6ccccc6-c5c4c4c3cccc4)c2)n1 OLLZUKMBACPRLE-UHFFFAOYSA-N 0.000 description 1
- RZFFLWARBPBEQY-UHFFFAOYSA-N c(cc1)ccc1N1c(c(c2ccccc22)c(cc3)[n]2-c(cc2)cc4c2[o]c2ccccc42)c3-c(cccc2)c2-c2ccccc12 Chemical compound c(cc1)ccc1N1c(c(c2ccccc22)c(cc3)[n]2-c(cc2)cc4c2[o]c2ccccc42)c3-c(cccc2)c2-c2ccccc12 RZFFLWARBPBEQY-UHFFFAOYSA-N 0.000 description 1
- BSIBLQFGAUUNNL-UHFFFAOYSA-N c(cc1)ccc1N1c(c(c2ccccc22)c(cc3)[n]2-c2nc(cccc4)c4c(-c(cc4)ccc4-c4cccc5c4cccc5)n2)c3-c(cccc2)c2-c2ccccc12 Chemical compound c(cc1)ccc1N1c(c(c2ccccc22)c(cc3)[n]2-c2nc(cccc4)c4c(-c(cc4)ccc4-c4cccc5c4cccc5)n2)c3-c(cccc2)c2-c2ccccc12 BSIBLQFGAUUNNL-UHFFFAOYSA-N 0.000 description 1
- QRLZMAYAFYUAQW-UHFFFAOYSA-N c(cc1)ccc1N1c(c2c(cc3)c4cnccc4[n]2-c2nc(cccc4)c4c(-c(cc4)ccc4-c4cccc5c4cccc5)n2)c3-c2ccccc2-c2ccccc12 Chemical compound c(cc1)ccc1N1c(c2c(cc3)c4cnccc4[n]2-c2nc(cccc4)c4c(-c(cc4)ccc4-c4cccc5c4cccc5)n2)c3-c2ccccc2-c2ccccc12 QRLZMAYAFYUAQW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1033—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1037—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
Abstract
Description
본 발명은 신규 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic compound and an organic electroluminescent device including the same.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 유기물층으로 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 상기 유기물층에 포함되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다.In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic layer in the anode, and electrons are injected into the organic layer in the cathode. When the injected holes and electrons meet, an exciton is formed. When the exciton falls to the ground state, light is emitted. The material contained in the organic material layer may be classified into a light emitting material, a hole injecting material, a hole transporting material, an electron transporting material, an electron injecting material, or the like depending on its function.
상기 발광 물질은 발광색에 따라 청색, 녹색, 적색의 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색의 발광 물질로 구분될 수 있다. 또한 색순도의 증가와 에너지 전이를 통해 발광 효율을 증가시키기 위하여 발광 물질로서 호스트/도판트 계를 사용할 수 있다.The luminescent material may be classified into blue, green, and red luminescent materials according to luminescent colors, and yellow and orange luminescent materials necessary to realize better natural colors. A host / dopant system can be used as a luminescent material to increase the luminous efficiency through increase of color purity and energy transfer.
도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때 인광 도판트는 이론적으로 형광 도판트에 비해 최대 4배의 발광 효율을 향상시킬 수 있기 때문에 인광 도판트 뿐만 아니라 인광 호스트에 대한 연구가 많이 진행되고 있다.The dopant material can be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. Since the phosphorescent dopant can theoretically improve the luminous efficiency up to 4 times as compared with the fluorescent dopant, studies on the phosphorescent dopant as well as the phosphorescent host have been conducted.
현재 발광층에 사용되는 형광 도판트/호스트 물질로는 안트라센 유도체들이 알려져 있다. 또한 발광층에 사용되는 인광 도판트 물질로는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등의 Ir을 포함하는 금속 착체 화합물이 알려져 있고, 인광 호스트 물질로는 4,4-dicarbazolybiphenyl(CBP)가 알려져 있다.Currently, anthracene derivatives are known as fluorescent dopant / host materials used in the light emitting layer. As phosphorescent dopant materials used for the light emitting layer, metal complex compounds including Ir such as Firpic, Ir (ppy) 3 , (acac) Ir (btp) 2 and the like are known. As phosphorescent host materials, 4,4-dicarbazolybiphenyl (CBP) is known.
그러나 기존의 재료들은 유리전이온도가 낮아 열적 안정성이 떨어지기 때문에 유기 전계 발광 소자의 수명 측면에서 만족할 만한 수준이 되지 못하고 있으며, 발광 특성 측면에서도 여전히 개선이 필요하다.However, since the conventional materials have low glass transition temperature and thermal stability is poor, the lifetime of the organic electroluminescent device is not satisfactory and the improvement of the luminescent characteristics is still required.
상기한 문제점을 해결하기 위해 본 발명은 유리전이온도가 높고, 열적 안정성이 우수하며, 정공과 전자의 결합력을 향상시킬 수 있는 유기 화합물을 제공하는 것을 목적으로 한다.In order to solve the above problems, it is an object of the present invention to provide an organic compound having a high glass transition temperature, an excellent thermal stability, and an ability to improve the bonding force between holes and electrons.
또 본 발명은 상기 유기 화합물을 포함하여 구동전압 및 발광효율이 향상된 유기 전계 발광 소자를 제공하는 것도 목적으로 한다.It is another object of the present invention to provide an organic electroluminescent device including the organic compound and having improved driving voltage and luminous efficiency.
상기한 목적을 달성하기 위해 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.In order to accomplish the above object, the present invention provides a compound represented by the following general formula (1).
[화학식 1][Chemical Formula 1]
상기 화학식 1에서,In Formula 1,
Y1 내지 Y12는 각각 독립적으로 C(R1) 또는 N이고, 이때, Y1과 Y2, Y2와 Y3, Y3와 Y4, Y5와 Y6, Y6과 Y7, Y7과 Y8, Y9와 Y10, Y10과 Y11 및 Y11과 Y12 중 하나는 모두 C(R1)이되, 서로 결합하여 하기 화학식 2로 표시되는 축합 고리를 형성하고,Y 1 to Y 12 are each independently C (R 1 ) or N, wherein Y 1 and Y 2 , Y 2 and Y 3 , Y 3 and Y 4 , Y 5 and Y 6 , Y 6 and Y 7 , Y 7 and Y 8 , Y 9 and Y 10 , Y 10 and Y 11, and Y 11 and Y 12 are both C (R 1 ), and are bonded to each other to form a condensed ring represented by the following formula (2)
[화학식 2](2)
상기 화학식 2에서, 점선은 상기 화학식 1과 결합되는 부분이고,In the formula (2), the dotted line is a moiety bonded to the formula (1)
상기 화학식 1 및 2에서,In the above Formulas 1 and 2,
X1 및 X2는 각각 독립적으로 N(Ar1), O, S, C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고, 이때, 적어도 하나는 N(Ar1)이며,X 1 and X 2 are each independently selected from the group consisting of N (Ar 1 ), O, S, C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ) N (Ar < 1 >),
Y13 내지 Y16은 각각 독립적으로 C(R2) 또는 N이고,Y 13 to Y 16 are each independently C (R 2 ) or N,
Ar1 내지 Ar5는 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되고,Ar 1 to Ar 5 each independently represent a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms A C 6 to C 60 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 60 arylamine group, a C 3 to C 40 cycloalkyl group, a heterocyclic group having 3 to 40 nuclear atoms alkyl group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic of, C 6 ~ C 60 aryl phosphine group, C 6 ~ aryl phosphine of C 60 A pentacene group, a pin oxide group, and an arylsilyl group of C 6 to C 60 ,
축합 고리를 형성하지 않는 복수의 R1 및 R2는 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,A plurality of R which does not form a condensed ring 1 and R 2 are each independently hydrogen, deuterium, a halogen, a cyano group, a nitro group, C 1 ~ alkenyl group of the C 40 alkyl group, C 2 ~ C 40 of, C 2 ~ C A C 3 to C 40 cycloalkyl group, a heterocyclic cycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkenyl group, C 6 -C 60 aryloxy groups, C 1 -C 40 alkylsilyl groups, C 6 -C 60 arylsilyl groups, C 1 -C 40 alkylboron groups, C 6 -C 60 the arylboronic group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ selected from the group consisting of an aryl amine of the C 60 or the, form a condensed ring by combining adjacent tile In addition,
상기 Ar1 내지 Ar5, R1 및 R2의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있다. 여기서 Ar1 내지 Ar5, R1 및 R2가 복수의 치환기로 치환될 경우 복수의 치환기는 서로 동일하거나 상이할 수 있다.The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group and arylsilyl group of Ar 1 to Ar 5, R 1 and R 2 , An alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group and an arylamine group are each independently a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkoxy group, group, C 3 ~ C 40 cycloalkyl group, the number of nuclear atoms of 3 to 40 hetero cycloalkyl, heteroaryl of C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 aryl group, C 1 ~ C 40 alkyloxy A C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, C 6 ~ C 60 aryl phosphine group of, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C to 1 or more substituents selected from the 60 group consisting of aryl amines may be unsubstituted or substituted The. When Ar 1 to Ar 5 , R 1 and R 2 are substituted with a plurality of substituents, the plurality of substituents may be the same or different from each other.
한편 본 발명은 양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.According to another aspect of the present invention, there is provided an organic electroluminescent device comprising a cathode, a cathode, and at least one organic layer sandwiched between the anode and the cathode, wherein at least one of the one or more organic layers includes a compound represented by the above formula And an organic electroluminescent device.
본 발명에서 알킬은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, alkyl means a monovalent substituent derived from a linear or branched saturated hydrocarbon having 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl and hexyl.
본 발명에서 알케닐(alkenyl)은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, alkenyl means a monovalent substituent derived from a straight-chain or branched-chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, 2-butenyl, and the like.
본 발명에서 알키닐(alkynyl)은 탄소-탄소 삼중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, alkynyl means a monovalent substituent derived from a straight-chain or branched-chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond. Examples thereof include, but are not limited to, ethynyl, 2-propynyl, and the like.
본 발명에서 아릴은 단독 고리 또는 2 이상의 고리가 조합된 탄소수 6 내지 60의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, aryl means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined. Also, a form in which two or more rings are pendant or condensed with each other may be included. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
본 발명에서 헤테로아릴은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함될 수 있다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리, 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, heteroaryl means a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms. Wherein at least one of the carbons, preferably one to three carbons, is replaced by a heteroatom such as N, O, S or Se. It is also possible to include a form in which two or more rings are pendant or condensed with each other, and further, a condensed form with an aryl group may be included. Examples of such heteroaryls include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolizinyl, indolyl indolyl), purinyl, quinolyl, benzothiazole, carbazolyl, and heterocyclic rings such as 2-furanyl, N-imidazolyl, 2- , 2-pyridinyl, 2-pyrimidinyl, and the like, but are not limited thereto.
본 발명에서 아릴옥시는 RO-로 표시되는 1가의 치환기로, 상기 R은 탄소수 6 내지 60의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, aryloxy is a monovalent substituent represented by RO-, and R represents aryl having 6 to 60 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.
본 발명에서 알킬옥시는 R'O-로 표시되는 1가의 치환기로, 상기 R'는 탄소수 1 내지 40의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, alkyloxy is a monovalent substituent group represented by R'O-, wherein R 'represents alkyl having 1 to 40 carbon atoms, and includes a linear, branched or cyclic structure can do. Examples of alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy and pentoxy.
본 발명에서 아릴아민은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.In the present invention, arylamine refers to an amine substituted with aryl having 6 to 60 carbon atoms.
본 발명에서 시클로알킬은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, cycloalkyl means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
본 발명에서 헤테로시클로알킬은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, heterocycloalkyl means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, wherein at least one carbon atom, preferably 1 to 3 carbons, of the ring is N, O, S or Se Lt; / RTI > Examples of such heterocycloalkyl include, but are not limited to, morpholine, piperazine, and the like.
본 발명에서 알킬실릴은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, 아릴실릴은 탄소수 6 내지 60의 아릴로 치환된 실릴을 의미한다.In the present invention, alkylsilyl is silyl substituted with alkyl having 1 to 40 carbon atoms, and arylsilyl means silyl substituted with aryl having 6 to 60 carbon atoms.
본 발명에서 축합고리는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.In the present invention, the condensed rings refer to condensed aliphatic rings, condensed aromatic rings, condensed heteroaliphatic rings, condensed heteroaromatic rings, or a combination thereof.
본 발명의 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층(바람직하게는, 발광층의 발광 물질로)에 사용할 경우, 유기 전계 발광 소자의 효율(발광 효율 및 전령 효율), 수명, 휘도 및 구동전압 등을 향상시킬 수 있다. 따라서, 본 발명은 풀 칼라 유기 전계 발광 패널의 성능 및 수명을 향상시킬 수 있다.When the compound represented by the general formula (1) of the present invention is used for an organic material layer (preferably, a light emitting material of a light emitting layer) of an organic electroluminescent device, efficiency (luminous efficiency and messaging efficiency), lifetime, Voltage and the like can be improved. Accordingly, the present invention can improve the performance and lifetime of a full-color organic electroluminescent panel.
이하, 본 발명을 설명한다.
Hereinafter, the present invention will be described.
1. 유기 화합물1. Organic compounds
본 발명의 유기 화합물은 하기와 같은 트리벤조아제핀계 구조에 방향족 고리 또는 헤테로 방향족 고리가 축합되어 기본골격을 이루는 것으로, 상기 화학식 1로 표시된다. 여기서 상기 트리벤조아제핀계 구조에 축합되는 방향족 고리 또는 헤테로 방향족 고리는 특별히 한정되지 않으나, 인덴, 인돌, 벤조싸이오펜, 벤조퓨란, 벤조실롤 등을 들 수 있다.The organic compound of the present invention is a tribenzoazepin structure having an aromatic ring or a heteroaromatic ring condensed to form a basic skeleton as shown below. The aromatic ring or heteroaromatic ring condensed in the above-mentioned tribenzoazepin structure is not particularly limited, and examples thereof include indene, indole, benzothiophene, benzofuran, and benzoylol.
유기 전계 발광 소자에 포함되는 유기물층에서 인광 발광층에 포함되는 호스트는 삼중항 에너지 갭이 도펀트보다 높아야 한다. 즉, 도펀트로 부터 효과적으로 인광 발광을 제공하기 위해서는 호스트의 가장 낮은 여기 상태의 에너지가 도펀트의 가장 낮은 방출 상태의 에너지보다 높아야 한다. 본 발명의 화학식 1로 표시되는 화합물은 넓은 일중항 에너지 준위와 높은 삼중항 에너지 준위를 가지는 디벤조아제핀계 구조에 특정의 치환기가 도입되어 있어 발광층의 호스트로 적용할 경우 도펀트 보다 높은 에너지 준위를 나타낼 수 있다.The host included in the phosphorescent light emitting layer in the organic material layer included in the organic electroluminescent device must have a triplet energy gap higher than that of the dopant. That is, in order to effectively provide phosphorescence from the dopant, the energy of the lowest excitation state of the host should be higher than the energy of the lowest emission state of the dopant. The compound represented by the formula (1) of the present invention has a specific substituent group introduced into the dibenzoazepine structure having a broad singlet energy level and a high triplet energy level, and exhibits a higher energy level than a dopant when applied as a host of a light emitting layer .
또한 2.3eV 이상의 높은 삼중항에너지를 가지는 본 발명의 화학식 1로 표시되는 화합물은 발광층에서 생성된 엑시톤이 인접하는 전자수송층 또는 정공수송층으로 확산되는 것을 방지하여, 발광에 기여하는 엑시톤의 수를 증가시켜 발광 효율을 개선할 수 있다.In addition, the compound represented by Formula 1 of the present invention having a high triplet energy of 2.3 eV or more prevents the excitons produced in the light emitting layer from diffusing into the adjacent electron transporting layer or hole transporting layer, thereby increasing the number of excitons contributing to light emission The luminous efficiency can be improved.
또 본 발명의 화학식 1로 표시되는 화합물은 도입되는 치환기에 따라 HOMO 및 LUMO에너지 레벨이 조절되어 넓은 밴드갭을 가질 수 있고, 높은 캐리어 수송성을 가질 수 있다. 이외에도 전자 흡수성이 큰 전자 끌개기(EWG) 및/또는 전자 공여성이 큰 전자 주게기(EDG)가 결합될 경우, 분자 전체가 바이폴라(bipolar) 특성을 가져 정공과 전자의 결합력을 높일 수 있다. In addition, the compound represented by the general formula (1) of the present invention can have a wide bandgap by controlling the HOMO and LUMO energy levels according to the substituent to be introduced, and can have a high carrier transporting property. In addition, when an electron donor (EWG) having a large electron absorbing property and / or a large electron donating group (EDG) having an electron donating property are combined, the entire molecule can have a bipolar characteristic, thereby enhancing the bonding strength between the hole and the electron.
한편 본 발명의 화학식 1로 표시되는 화합물은 상기 기본 골격에 다양한 치환체, 특히 아릴기 및/또는 헤테로아릴기가 도입되어 화합물의 분자량이 유의적으로 증대됨으로써, 유리 전이온도가 향상되어 종래의 유기물층 재료(예를 들어, CBP)보다 높은 열적 안정성을 가질 수 있다. 또한, 상기 화학식 1로 표시되는 화합물은 유기물층의 결정화 억제에도 효과가 있다.Meanwhile, the compound represented by the formula (1) of the present invention has various substituents, especially an aryl group and / or a heteroaryl group, introduced into the basic skeleton and the molecular weight of the compound is significantly increased to improve the glass transition temperature, For example, CBP). ≪ / RTI > The compound represented by the formula (1) is also effective for inhibiting crystallization of the organic material layer.
따라서 본 발명의 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층에 적용할 경우 유기 전계 발광 소자의 성능 및 수명 특성이 크게 향상될 수 있다. 또한 이러한 유기 전계 발광 소자 수명 향상은 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.Accordingly, when the compound represented by Formula 1 of the present invention is applied to an organic material layer of an organic electroluminescent device, the performance and lifetime characteristics of the organic electroluminescent device can be greatly improved. Further, the lifetime of the organic electroluminescent device can be maximized by maximizing the performance of the full-color organic electroluminescent panel.
이러한 본 발명의 화학식 1로 표시되는 화합물에서, X1 및 X2는 각각 독립적으로 N(Ar1), O, S, C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되는데, 유기 전계 발광 소자의 특성을 고려할 때, N(Ar1), O 또는 S인 것이 바람직하며, 모두 N(Ar1)인 것이 더욱 바람직하다. 또한 Y1 내지 Y12는 각각 독립적으로 C(R1) 또는 N인데, 유기 전계 발광 소자의 특성을 고려할 때, N을 1개 포함하거나, 모두 C(R1)인 것이 바람직하다. 또 Y13 내지 Y16은 각각 독립적으로 C(R2) 또는 N인데, 유기 전계 발광 소자의 특성을 고려할 때, N을 1개 포함하거나, 모두 C(R2)인 것이 바람직하다.In these compounds represented by the general formula (I) of the present invention, X 1 and X 2 are independently N (Ar 1), O, S, C (Ar 2) (Ar 3) and Si (Ar 4) (Ar 5 ) , respectively are selected from the group, given the characteristics of the organic EL device, preferably a N (Ar 1), O or S, and more preferably all of the N (Ar 1) made of a. Y 1 to Y 12 are each independently C (R 1 ) or N, and in consideration of the characteristics of the organic electroluminescent device, it is preferable that one or all of N is C (R 1 ). Y 13 to Y 16 are each independently C (R 2 ) or N, and in consideration of the characteristics of the organic electroluminescent device, it is preferable that one or all of N is C (R 2 ).
이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 3 내지 화학식 11로 표시되는 화합물 중 어느 하나로 구체화될 수 있다.The compound represented by formula (1) of the present invention may be any one of compounds represented by the following formulas (3) to (11).
[화학식 3](3)
[화학식 4] [Chemical Formula 4]
[화학식 5][Chemical Formula 5]
[화학식 6][Chemical Formula 6]
[화학식 7](7)
[화학식 8][Chemical Formula 8]
[화학식 9][Chemical Formula 9]
[화학식 10][Chemical formula 10]
[화학식 11](11)
상기 화학식 3 내지 11에서, X1, X2, R1 및 R2는 상기 화학식 1에서 정의한 바와 동일하며, 이때, 복수의 R1은 서로 동일하거나 상이고, 복수의 R2는 서로 동일하거나 상이하다.X 1 , X 2 , R 1, and R 2 are the same as defined in Formula 1, wherein a plurality of R 1 s are the same or different from each other, and a plurality of R 2 s are the same as or different from each other .
이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 12 내지 20으로 표시되는 화합물 중 어느 하나로 더욱 구체화될 수 있다.The compound represented by the formula (1) of the present invention may be further compounded by any one of the compounds represented by the following formulas (12) to (20).
[화학식 12][Chemical Formula 12]
[화학식 13] [Chemical Formula 13]
[화학식 14][Chemical Formula 14]
[화학식 15][Chemical Formula 15]
[화학식 16] [Chemical Formula 16]
[화학식 17][Chemical Formula 17]
[화학식 18][Chemical Formula 18]
[화학식 19][Chemical Formula 19]
[화학식 20][Chemical Formula 20]
상기 화학식 12 내지 20에서, Ar1R1 및 R2는 상기 화학식 1에서 정의한 바와 동일하며, 이때, 복수의 R1은 서로 동일하거나 상이고, 복수의 R2는 서로 동일하거나 상이하다.In the general formulas (12) to (20), Ar 1 R 1 and R 2 are the same as defined in the general formula (1), wherein a plurality of R 1 s are the same or different from each other and a plurality of R 2 s are the same as or different from each other.
또한 본 발명의 화학식 1로 표시되는 화합물에서, Ar1내지 Ar5는 화합물의 넓은 밴드갭과 열적 안정성을 고려할 때, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 C6~C60의 아릴아민기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되는 것이 바람직하다. 특히, Ar1이 C6~C60의 아릴기 또는 핵원자수 5 내지 60의 헤테로아릴기인 것이 더욱 바람직하다.In the compounds represented by the general formula (1) of the present invention, Ar 1 to Ar 5 are each independently a C 6 to C 60 aryl group, a heteroaryl group C having 5 to 60 nuclear atoms to be 6 ~ C 60 aryl group and a C 6 ~ amine selected from the group consisting of aryl silyl C 60 are preferred. In particular, Ar 1 is C 6 ~ C 60 heteroaryl group of the aryl group or 5 to 60 nuclear atoms is more preferable.
또 본 발명의 화학식 1로 표시되는 화합물에서, R1 및R2는 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 것이 바람직하다.In the compound represented by Formula 1 of the present invention, R 1 and R 2 are each independently selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 6 to C 60 aryl, A heteroaryl group having 5 to 60 nuclear atoms and an arylamine group having 6 to 60 carbon atoms.
구체적으로, 상기 Ar1R1 및R2 중 적어도 하나는 하기 화학식 21로 표시되는 치환기인 것이 바람직하다.Specifically, it is preferable that at least one of Ar 1 R 1 and R 2 is a substituent represented by the following formula (21).
[화학식 21][Chemical Formula 21]
상기 화학식 21에서, In Formula 21,
L은 단일결합, C6~C40의 아릴렌기 및 핵원자수 5 내지 40의 헤테로아릴렌기로 이루어진 군에서 선택되는데, 그 중에서도 단일결합, 페닐렌 또는 비페닐렌인 것이 바람직하다.L is are selected from the group consisting of a single bond, a C 6 ~ C 40 aryl group and a nuclear atoms of 5 to 40 hetero arylene group for, particularly preferably a single bond, phenylene or biphenylene.
Z1 내지 Z5는 각각 독립적으로 N 또는 C(R17)이고, 이때, 적어도 하나는 N을 포함하는데, 구체적으로는 1 내지 3개의 N을 포함하는 것이 바람직하다.Z 1 to Z 5 are each independently N or C (R 17 ), and at least one of them includes N, specifically, it is preferable to include 1 to 3 N.
상기 R17은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 인접한 기와 결합하여 축합 고리를 형성할 수 있다.Wherein R 17 is selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 alkynyl, C 3 to C 40 cycloalkyl , A heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group A C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine A pin group, an arylphosphine oxide group having 6 to 60 carbon atoms, and an arylamine group having 6 to 60 carbon atoms, or may be bonded to an adjacent group to form a condensed ring.
여기서 상기 L의 아릴렌기, 헤테로아릴렌기와, 상기 R17의 알킬기, 알케닐기, 알키닐기, 시틀로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있다.Wherein L in the arylene group, heteroarylene group, wherein R 17 an alkyl group, an alkenyl group, an alkynyl group, a siteul group, a heterocycloalkyl group, an aryl group, a heteroaryl group, alkyloxy group, aryloxy group, alkyl silyl group , aryl silyl group, an alkyl boron group, an aryl boron group, an aryl phosphine group, aryl phosphine oxide group and an arylamine group, each independently, C 1 ~ alkenyl group of the C 40 alkyl group, C 2 ~ C 40 of, C 2 ~ alkynyl group of C 40, C 3 ~ C 40 cycloalkyl group, the number of nuclear atoms of 3 to 40 of the heterocycloalkyl of the alkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyl silyl group, the group C 6 ~ C 60 aryl silyl, C 1 ~ group alkylboronic of C 40, C 6 ~ C 60 arylboronic group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ substituted 1 or more selected from the group consisting of an aryl amine of the C 60 of the As may be unsubstituted or substituted.
이러한 화학식 21로 표시되는 치환기는 하기 화학식 A-1 내지 A-15로 표시되는 치환기 중 어느 하나로 구체화될 수 있다.The substituent represented by the formula (21) may be embodied by any one of substituents represented by the following formulas (A-1) to (A-15).
상기 화학식 A-1 내지 A-15 에서,In the above formulas A-1 to A-15,
L 및 R17은 상기 화학식 21에서 정의한 바와 동일하고, 이때, 복수의 R17은 서로 동일하거나 상이하며,L And R 17 are the same as defined in the above formula (21), wherein a plurality of R 17 s are the same as or different from each other,
R21은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성할 수 있고,R 21 is selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 alkynyl, C 3 to C 40 cycloalkyl, aryloxy nuclear atoms 3 to 40 of the heterocycloalkyl of the alkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, C 6 ~ C 60, alkyloxy group of C 1 ~ C 40 , An arylamine group of C 6 to C 60 , a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine group , C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ selected from the group consisting of C 60 or aryl silyl, by combining groups of adjacent, may form a condensed ring,
상기 R21의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있으며,Alkyl group of the R 21, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, an arylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, the arylphosphine oxide group and the arylamine group are each independently a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 3 to C 40 cycloalkyl group, alkyl, nuclear atoms of 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 of the heteroaryl group, C 1 ~ C 40 alkyloxy group of, C of 6 ~ C 60 aryl oxy group, C 1 ~ C 40 alkylsilyl group, C group 6 ~ C 60 aryl silyl, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic in, aryl of C 6 ~ C 60 phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl amines may be unsubstituted or substituted by one substituent at least one selected from the group consisting of,
n은 0 내지 4의 정수이다.n is an integer of 0 to 4;
구체적으로, 본 발명의 화학식 1로 표시되는 화합물에서 Ar1 내지 Ar5R1 및 R2은 각각 독립적으로 수소 또는 하기 S1 내지 S204로 표시되는 치환기로 이루어진 군에서 선택되는 것이 바람직하다.Specifically, in the compound represented by the general formula (1) of the present invention, Ar 1 to Ar 5 R 1 and R 2 are each independently selected from the group consisting of hydrogen or the substituents represented by the following S1 to S204.
본 발명의 화학식 1로 표시되는 화합물은 하기 예시된 화합물들로 구체화될 수 있으나, 본 발명의 화학식 1로 표시되는 화합물이 하기 화합물들로 한정되는 것은 아니다.The compound represented by the formula (1) of the present invention can be embodied by the following exemplified compounds, but the compound represented by the formula (1) of the present invention is not limited to the following compounds.
2. 유기 전계 발광 소자2. Organic electroluminescent device
본 발명은 양극(anode), 음극(cathode) 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다. 이때, 상기 화합물은 단독으로 사용되거나, 또는 2 이상이 혼합되어 사용될 수 있다.The present invention relates to an organic electroluminescent device comprising at least an anode, a cathode, and at least one organic layer sandwiched between the anode and the cathode, wherein at least one of the one or more organic layers includes a compound represented by Formula 1 An organic electroluminescent device is provided. At this time, the compounds may be used alone or in combination of two or more.
상기 1층 이상의 유기물층은 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 전자 주입층 중 어느 하나 이상일 수 있다. 여기서 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 발광층인 것이 바람직하다.The one or more organic material layers may be at least one of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. Here, the organic compound layer including the compound represented by Formula 1 is preferably a light emitting layer.
본 발명의 유기 전계 발광 소자의 발광층은 호스트 재료를 포함할 수 있는데, 이때 호스트 재료로 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 상기 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 발광층 재료, 바람직하게는 청색, 녹색, 적색의 인광 호스트 재료로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에, 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등을 향상시킬 수 있다.The light emitting layer of the organic electroluminescent device of the present invention may include a host material, wherein the host material may include a compound represented by the above formula (1). When the compound represented by Formula 1 is contained as a light emitting layer material of an organic electroluminescent device, preferably a blue, green, or red phosphorescent host material, the bonding strength between holes and electrons in the light emitting layer is increased. (Luminous efficiency and power efficiency), lifetime, luminance, driving voltage and the like can be improved.
본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 상기 전자 수송층 위에는 전자 주입층이 추가로 적층될 수 있다.The structure of the organic electroluminescent device of the present invention is not particularly limited, but may be a structure in which a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode are sequentially laminated. An electron injection layer may be further stacked on the electron transport layer.
또한 본 발명의 유기 전계 발광 소자의 구조는 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층될 뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.Further, the structure of the organic electroluminescent device of the present invention may be a structure in which an anode, one or more organic material layers and a cathode are sequentially laminated, and an insulating layer or an adhesive layer is inserted into the interface between the electrode and the organic material layer.
본 발명의 유기 전계 발광 소자는 상기 유기물층 중 1층 이상 (예컨대, 발광층)이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는, 당업계에 공지된 재료 및 방법을 이용하여 다른 유기물층 및 전극을 형성하여 제조될 수 있다.The organic electroluminescent device of the present invention may be formed by using materials and methods known in the art, except that at least one of the organic layers (for example, the light emitting layer) includes the compound represented by the above formula (1) And electrodes.
상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에 한정되지 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
본 발명의 유기 전계 발광 소자에 포함되는 기판으로는 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등이 사용될 수 있다.As the substrate included in the organic electroluminescent device of the present invention, a silicon wafer, quartz, a glass plate, a metal plate, a plastic film and a sheet can be used.
또 양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등이 사용될 수 있다.Examples of the positive electrode material include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black may be used.
또한 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 사용될 수 있다.The negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or an alloy thereof and a multilayer such as LiF / Al or LiO 2 / Structural materials and the like can be used.
또 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당 업계에 알려진 통상의 물질이 사용될 수 있다.
The hole injecting layer, the hole transporting layer, the electron injecting layer and the electron transporting layer are not particularly limited, and ordinary materials known in the art can be used.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited by the following examples.
[준비예 1] IAz-1의 합성[Preparation Example 1] Synthesis of IAz-1
<단계 1> 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine의 합성Synthesis of 7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 7-chloro-9H-tribenzo[b,d,f]azepine (150g, 540.0 mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150 g, 594 mmol), Pd(dppf)Cl2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) 및 1,4-dioxane (2000 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 methylene chloride로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:2 (v/v))로 정제하여 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (149 g, 수율 : 75 %)을 얻었다.A solution of 7-chloro-9H-tribenzo [b, d, f] azepine (150 g, 540.0 mol), 4,4,4 ', 4,5,5,5,5- '-bi (1,3,2-dioxaborolane) ( 150 g, 594 mmol), Pd (dppf) Cl 2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) and 1,4-dioxane (2000 ml) were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the organic layer was extracted with methylene chloride. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (Hexane: MC = 3: 2 (v / v)) to obtain 7- (4,4,5,5- -1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine (149 g, yield 75%).
1H-NMR: δ 1.24 (s, 12H), 6.50 (s, 1H), 6.69 (m, 1H), 6.87 (m, 1H), 7.16-7.17 (m, 2H), 7.47-7.54 (m, 4H), 7.85 (m, 2H) 1 H-NMR: δ 1.24 ( s, 12H), 6.50 (s, 1H), 6.69 (m, 1H), 6.87 (m, 1H), 7.16-7.17 (m, 2H), 7.47-7.54 (m, 4H ), 7.85 (m, 2H)
<단계 2> 7-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine의 합성<Step 2> Synthesis of 7- (2-nitrophenyl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (148 g, 403 mmol), 1-iodo-2-nitrobenzene (100 g, 403 mmol) 및 Pd(PPh3)4 (23 g, 20 mmol)를 혼합한 다음, K2CO3 (167 g, 1210 mmol), 1,4-dioxane (1600 ml), H2O (400 ml)를 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 ethyl acetate로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:1 (v/v))로 정제하여 7-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (99 g, 수율 : 68 %)을 얻었다.(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine (148 g, 403 mmol) iodo-2-nitrobenzene (100 g, 403 mmol) and Pd (PPh 3 ) 4 (23 g, 20 mmol) were mixed and K 2 CO 3 (167 g, 1210 mmol), 1,4- ml) and H 2 O (400 ml) were added, and the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain 7- (2-nitrophenyl) -9H- d, f] azepine (99 g, yield: 68%).
1H-NMR: δ 4.0 (s, 1H), 6.61-6.69 (m, 2H), 6.87-6.95 (m, 2H), 7.16 (m, 1H), 7.47-7.67 (m, 5H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR: δ 4.0 ( s, 1H), 6.61-6.69 (m, 2H), 6.87-6.95 (m, 2H), 7.16 (m, 1H), 7.47-7.67 (m, 5H), 7.85-7.90 (m, 3 H), 8.00-8. 05 (m, 2 H)
<단계 3> 7-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine의 합성<Step 3> Synthesis of 7- (2-nitrophenyl) -9-phenyl-9H-tribenzo [b, d, f] azepine
질소 기류 하에서 7-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (99 g. 271 mmol), iodobenzene(55 g, 271 mmol), Cu (8.6 g, 135 mmol), K2CO3 (112 g, 815 mmol) 및 nitrobenzene (990 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후, nitrobenzene을 제거하고 methylene chloride로 추출한 후 컬럼크로마토그래피 (Hexane : MC = 5:1 (v/v))로 정제하여 7-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (86 g, 수율 : 72%)을 얻었다.Iodobenzene (55 g, 271 mmol), Cu (8.6 g, 135 mmol), K 2 (dibenzylideneacetone) CO 3 (112 g, 815 mmol) and nitrobenzene (990 ml) were mixed and stirred at 190 ° C for 12 hours. After completion of the reaction, nitrobenzene was removed and the residue was extracted with methylene chloride. The residue was purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to obtain 7- (2-nitrophenyl) -9-phenyl-9H-tribenzo [ , d, f] azepine (86 g, yield: 72%).
1H-NMR: δ 6.61-6.69 (m, 4H), 6.81-6.95 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.67 (m, 5H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR: δ 6.61-6.69 ( m, 4H), 6.81-6.95 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.67 (m, 5H), 7.85-7.90 (m, 3H) , 8.00-8. 05 (m, 2H)
<단계 4> IAz-1의 합성<Step 4> Synthesis of IAz-1
반응기에 7-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine(86 g, 195 mmol), PPh3 (128 g, 488 mmol) 및 1,2-dichlorobenzene (880 ml)을 혼합 후, 12시간 동안 교반하였다. 반응 종결 후 ethyl acetate로 추출하고 컬럼크로마토그래피 (Hexane : MC = 2:1 (v/v))로 정제하여 IAz-1 (59 g, 수율 : 74 %)을 얻었다.Dibenzo [b, d, f] azepine (86 g, 195 mmol), PPh 3 (128 g, 488 mmol) and 1,2-dichlorobenzene (880 ml) were mixed and stirred for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate and purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain IAz-1 (59 g, yield: 74%).
1H-NMR: δ 6.63-6.69 (m, 3H), 6.81-6.87 (m, 2H), 7.16-7.29 (m, 4H), 7.47-7.63 (m, 7H), 7.80-7.85 (m, 2H), 8.12 (m, 1H), 11.70 (s, 1H)
1 H-NMR: δ 6.63-6.69 ( m, 3H), 6.81-6.87 (m, 2H), 7.16-7.29 (m, 4H), 7.47-7.63 (m, 7H), 7.80-7.85 (m, 2H) , 8.12 (m, 1 H), 11.70 (s, 1 H)
[준비예 2] IAz-2의 합성[Preparation Example 2] Synthesis of IAz-2
<단계 1> 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine의 합성Synthesis of 6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 6-chloro-9H-tribenzo[b,d,f]azepine (150 g, 540.0 mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150 g, 594 mmol), Pd(dppf)Cl2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) 및 1,4-dioxane (2000 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 methylene chloride로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:2 (v/v))로 정제하여 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (155 g, 수율 : 78 %)을 얻었다.(150 g, 540.0 mol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2, (150 g, 594 mmol), Pd (dppf) Cl 2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) and 1,4-dioxane 2000 ml) were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the organic layer was extracted with methylene chloride. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: MC = 3: 2 (v / v)) to obtain 6- (4,4,5,5-tetramethyl -1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine (155 g, yield: 78%).
1H-NMR: δ 1.24 (s, 12H), 6.69 (m, 2H), 6.87 (m, 1H), 7.16-7.2 (m, 2H), 7.46-7.54 (m, 4H), 7.85 (m, 2H) 1 H-NMR: δ 1.24 ( s, 12H), 6.69 (m, 2H), 6.87 (m, 1H), 7.16-7.2 (m, 2H), 7.46-7.54 (m, 4H), 7.85 (m, 2H )
<단계 2> 6-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (155 g, 419 mmol), 1-iodo-2-nitrobenzene (104 g, 419 mmol) 및 Pd(PPh3)4 (24 g, 20 mmol)를 혼합한 다음, K2CO3 (174 g, 1259 mmol), 1,4-dioxane (1600 ml), H2O (400 ml)를 넣고서 110℃에서 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:1 (v/v))로 정제하여 6-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (107 g, 수율 : 70 %)을 얻었다.(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine (155 g, 419 mmol) iodo-2-nitrobenzene (104 g , 419 mmol) and Pd (PPh 3) 4 (24 g, 20 mmol) were mixed, and then, K 2 CO 3 (174 g , 1259 mmol), 1,4-dioxane (1600 ml) and H 2 O (400 ml) were added thereto, and the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the solvent was removed from the organic layer obtained by extraction with ethyl acetate and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain 6- (2-nitrophenyl) -9H-tribenzo [ , d, f] azepine (107 g, yield: 70%).
1H-NMR: δ 4.0 (s, 1H), 6.69-6.75 (m, 2H), 6.87 (m, 1H), 7.16 (m, 1H), 7.47-7.54 (m, 5H), 7.67 (m, 1H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR: δ 4.0 ( s, 1H), 6.69-6.75 (m, 2H), 6.87 (m, 1H), 7.16 (m, 1H), 7.47-7.54 (m, 5H), 7.67 (m, 1H ), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H)
<단계 3> 6-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine의 합성Step 3 Synthesis of 6- (2-nitrophenyl) -9-phenyl-9H-tribenzo [b, d, f] azepine
질소 기류 하에서 6-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (107 g. 293 mmol), iodobenzene(59 g, 293 mmol), Cu (9.3 g, 146 mmol), K2CO3 (121 g, 880 mmol) 및 nitrobenzene (990 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후, nitrobenzene을 제거하고 methylene chloride로 추출한 후 컬럼크로마토그래피 (Hexane : MC = 5:1 (v/v))로 정제하여 6-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (95 g, 수율 : 74%)을 얻었다.(107 g, 293 mmol), iodobenzene (59 g, 293 mmol), Cu (9.3 g, 146 mmol), K 2 (dibenzylideneacetone) CO 3 (121 g, 880 mmol) and nitrobenzene (990 ml) were mixed and stirred at 190 ° C for 12 hours. After completion of the reaction, nitrobenzene was removed and the residue was extracted with methylene chloride. The residue was purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to obtain 6- (2-nitrophenyl) -9-phenyl-9H-tribenzo [ , d, f] azepine (95 g, yield: 74%).
1H-NMR: δ 6.63-6.87 (m, 6H), 7.45-7.54 (m, 5H), 7.67 (m, 1H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR: δ 6.63-6.87 ( m, 6H), 7.45-7.54 (m, 5H), 7.67 (m, 1H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H)
<단계 4> IAz-2 의 합성<Step 4> Synthesis of IAz-2
반응기에 6-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (95 g, 215 mmol), PPh3 (141 g, 539 mmol) 및 1,2-dichlorobenzene (900 ml)을 혼합 후, 12시간 동안 교반하였다. 반응 종결 후 ethyl acetate로 추출하고 컬럼크로마토그래피 (Hexane : MC = 2:1 (v/v))로 정제하여 IAz-2 (67 g, 수율 : 76 %)을 얻었다.9-phenyl-9H-tribenzo [b, d, f] azepine (95 g, 215 mmol), PPh 3 (141 g, 539 mmol) and 1,2-dichlorobenzene ml) were mixed and stirred for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate and purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain IAz-2 (67 g, yield 76%).
1H-NMR: δ 6.63-6.87 (m, 6H), 7.16-7.29 (m, 4H), 7.47-7.63 (m, 5H), 7.85 (m, 2H), 7.99 (m, 1H), 8.12 (m, 1H)
1 H-NMR: δ 6.63-6.87 ( m, 6H), 7.16-7.29 (m, 4H), 7.47-7.63 (m, 5H), 7.85 (m, 2H), 7.99 (m, 1H), 8.12 (m , 1H)
[준비예 3] IAz-3의 합성[Preparation Example 3] Synthesis of IAz-3
<단계 1> 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine의 합성Synthesis of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 5-chloro-9H-tribenzo[b,d,f]azepine (150 g, 540.0 mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150 g, 594 mmol), Pd(dppf)Cl2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) 및 1,4-dioxane (2000 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후, methylene chloride로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:2 (v/v))로 정제하여 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (143 g, 수율 : 72 %)을 얻었다.B, d, f] azepine (150 g, 540.0 mol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl- (150 g, 594 mmol), Pd (dppf) Cl 2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) and 1,4-dioxane 2000 ml) were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the organic layer was extracted with methylene chloride. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (Hexane: MC = 3: 2 (v / v)) to obtain 5- (4,4,5,5- tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine (143 g, yield: 72%).
1H-NMR: δ 1.24 (s, 12H), 6.69 (m, 2H), 6.87 (m, 1H), 7.16-7.17 (m, 3H), 7.47-7.54 (m, 3H), 7.85 (m, 2H) 1 H-NMR:? 1.24 (s, 12H), 6.69 (m, 2H), 6.87 (m, 1H), 7.16-7.17 (m, 3H), 7.47-7.54 )
<단계 2> 5-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (143 g, 387 mmol), 1-iodo-2-nitrobenzene (96 g, 387 mmol) 및 Pd(PPh3)4 (22 g, 19 mmol)를 혼합한 다음, K2CO3 (160 g, 1161 mmol), 1,4-dioxane (1600 ml), H2O (400 ml)를 넣고서 110℃에서 12시간 동안 교반하였다. 반응 종결 후 ethyl acetate로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (98 g, 수율 : 70 %)을 얻었다.B, d, f] azepine (143 g, 387 mmol), 1- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- iodo-2-nitrobenzene (96 g, 387 mmol) and Pd (PPh 3 ) 4 (22 g, 19 mmol) were mixed and then K 2 CO 3 (160 g, 1161 mmol), 1,4- ml) and H 2 O (400 ml) were added thereto, and the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain 5- (2-nitrophenyl) -9H- d, f] azepine (98 g, yield: 70%).
1H-NMR: δ 4.0 (s, 1H), 6.65-6.69 (m, 2H), 6.87 (m, 1H), 7.16-7.21 (m, 2H), 7.40-7.54 (m, 4H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR: δ 4.0 ( s, 1H), 6.65-6.69 (m, 2H), 6.87 (m, 1H), 7.16-7.21 (m, 2H), 7.40-7.54 (m, 4H), 7.85-7.90 (m, 3 H), 8.00-8. 05 (m, 2 H)
<단계 3> 5-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -9-phenyl-9H-tribenzo [b, d, f] azepine
질소 기류 하에서 5-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (98 g. 268 mmol), iodobenzene(55 g, 268 mmol), Cu (8.5 g, 134 mmol), K2CO3 (111 g, 806 mmol) 및 nitrobenzene (990 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후, nitrobenzene을 제거하고 methylene chloride로 추출한 후 컬럼크로마토그래피 (Hexane : MC = 5:1 (v/v))로 정제하여 5-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (85 g, 수율 : 72%)을 얻었다.(98 g, 268 mmol), iodobenzene (55 g, 268 mmol), Cu (8.5 g, 134 mmol), K 2 (dibenzylideneacetone) CO 3 (111 g, 806 mmol) and nitrobenzene (990 ml) were mixed and stirred at 190 ° C for 12 hours. After completion of the reaction, nitrobenzene was removed and the residue was extracted with methylene chloride. The residue was purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to give 5- (2-nitrophenyl) -9-phenyl-9H-tribenzo [ , d, f] azepine (85 g, yield: 72%).
1H-NMR: δ 6.63-6.69 (m, 4H), 6.81-6.87 (m, 2H), 7.16-7.21 (m, 4H), 7.40-7.54 (m, 4H), 7.67 (m, 1H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR: δ 6.63-6.69 ( m, 4H), 6.81-6.87 (m, 2H), 7.16-7.21 (m, 4H), 7.40-7.54 (m, 4H), 7.67 (m, 1H), 7.85 -7.90 (m, 3H), 8.00-8.05 (m, 2H)
<단계 4> IAz-3의 합성<Step 4> Synthesis of IAz-3
반응기에 5-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (95 g, 215 mmol), PPh3 (141 g, 539 mmol) 및 1,2-dichlorobenzene (900 ml)을 혼합 후, 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하고 컬럼크로마토그래피 (Hexane : MC = 2:1 (v/v))로 정제하여 IAz-3 (61 g, 수율 : 70 %)을 얻었다.Dibenzo [b, d, f] azepine (95 g, 215 mmol), PPh 3 (141 g, 539 mmol) and 1,2-dichlorobenzene (900 ml) were mixed and stirred for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate and purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain IAz-3 (61 g, yield 70%).
1H-NMR: δ 6.63-6.69 (m, 3H), 6.81-6.87 (m, 3H), 7.16-7.34 (m, 5H), 7.47-7.63 (m, 5H), 7.85 (m, 2H), 8.12 (m, 1H), 11.70 (s, 1H)
1 H-NMR: δ 6.63-6.69 ( m, 3H), 6.81-6.87 (m, 3H), 7.16-7.34 (m, 5H), 7.47-7.63 (m, 5H), 7.85 (m, 2H), 8.12 (m, 1 H), 11.70 (s, 1 H)
[준비예 4] IAz-4의 합성[Preparation Example 4] Synthesis of IAz-4
<단계 1> 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine의 합성Synthesis of 8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 8-chloro-9H-tribenzo[b,d,f]azepine (150 g, 540.0 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150 g, 594 mmol), Pd(dppf)Cl2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) 및 1,4-dioxane ( 2000 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후, methylene chloride로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:2 (v/v))로 정제하여 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (137 g, 수율 : 69 %)을 얻었다.B, d, f] azepine (150 g, 540.0 mmol), 4,4,4 ', 4', 5,5,5 ' (150 g, 594 mmol), Pd (dppf) Cl 2 (14 g, 16 mmol), KOAc (152 g, 1620.0 mmol) and 1,4-dioxane 2000 ml) were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the organic layer was extracted with methylene chloride, the solvent was removed from the organic layer, and the residue was purified by column chromatography (Hexane: MC = 3: 2 (v / v)) to obtain 8- (4,4,5,5- tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine (137 g, yield 69%).
1H-NMR: δ 1.24 (s, 12H), 6.69 (m, 1H), 6.87 (m, 2H), 7.16 (m, 1H), 7.46-7.54 (m, 4H), 7.85 (m, 2H) 1 H-NMR: δ 1.24 ( s, 12H), 6.69 (m, 1H), 6.87 (m, 2H), 7.16 (m, 1H), 7.46-7.54 (m, 4H), 7.85 (m, 2H)
<단계 2> 8-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine의 합성<Step 2> Synthesis of 8- (2-nitrophenyl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (137 g, 371 mmol), 1-iodo-2-nitrobenzene (92 g, 371 mmol) 및 Pd(PPh3)4 (21 g, 18 mmol)를 혼합한 다음, K2CO3 (153 g, 1113 mmol), 1,4-dioxane (1600 ml), H2O (400 ml)를 넣고서 110℃에서 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:1 (v/v))로 정제하여 8-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (100 g, 수율 : 74 %)을 얻었다.B, d, f] azepine (137 g, 371 mmol), 1- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- iodo-2-nitrobenzene (92 g, 371 mmol) and Pd (PPh 3 ) 4 (21 g, 18 mmol) were mixed and K 2 CO 3 (153 g, 1113 mmol), 1,4- ml) and H 2 O (400 ml) were added thereto, and the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the solvent was removed from the organic layer obtained by extraction with ethyl acetate, and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain 8- (2-nitrophenyl) -9H-tribenzo [b , d, f] azepine (100 g, yield: 74%).
1H-NMR: δ 4.0 (s, 1H), 6.69 (m, 1H), 6.87-6.93 (m, 2H), 7.16 (m, 1H), 7.47-7.54 (m, 5H), 7.67 (m, 1H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR: δ 4.0 ( s, 1H), 6.69 (m, 1H), 6.87-6.93 (m, 2H), 7.16 (m, 1H), 7.47-7.54 (m, 5H), 7.67 (m, 1H ), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H)
<단계 3> 8-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine의 합성Step 3 Synthesis of 8- (2-nitrophenyl) -9-phenyl-9H-tribenzo [b, d, f] azepine
질소 기류 하에서 8-(2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (100 g. 274 mmol), iodobenzene(55 g, 274 mmol), Cu (8.7 g, 137 mmol), K2CO3 (113 g, 823 mmol) 및 nitrobenzene (990 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후, nitrobenzene을 제거하고 methylene chloride로 추출한 후 컬럼크로마토그래피 (Hexane : MC = 5:1 (v/v))로 정제하여 8-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (91 g, 수율 : 76%)을 얻었다.(100 g, 274 mmol), iodobenzene (55 g, 274 mmol), Cu (8.7 g, 137 mmol), K 2 (dibenzylideneacetone) CO 3 (113 g, 823 mmol) and nitrobenzene (990 ml) were mixed and stirred at 190 ° C for 12 hours. After completion of the reaction, nitrobenzene was removed and the residue was extracted with methylene chloride. The residue was purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to give 8- (2-nitrophenyl) -9-phenyl-9H-tribenzo [ , d, f] azepine (91 g, yield: 76%).
1H-NMR: δ 6.63-6.69 (m, 3H), 6.81-6.93 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.54 (m, 5H), 7.67 (m, 1H), 7.85-7.90 (m, 3H), 8.00-8.05 (m, 2H) 1 H-NMR:? 6.63-6.69 (m, 3H), 6.81-6.93 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.54 -7.90 (m, 3H), 8.00-8.05 (m, 2H)
<단계 4> IAz-4의 합성<Step 4> Synthesis of IAz-4
반응기에 8-(2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (91 g, 206 mmol), PPh3 (135 g, 516 mmol) 및 1,2-dichlorobenzene (880 ml)을 혼합 후, 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하고 컬럼크로마토그래피 (Hexane : MC = 2:1 (v/v))로 정제하여 IAz-4 (59 g, 수율 : 71 %)을 얻었다.Dibenzo [b, d, f] azepine (91 g, 206 mmol), PPh 3 (135 g, 516 mmol) and 1,2-dichlorobenzene (880 ml) were mixed and stirred for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate and purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain IAz-4 (59 g, yield: 71%).
1H-NMR: δ 6.63-6.69 (m, 3H), 6.81-6.87 (m, 2H), 7.05 (m, 1H), 7.16-7.29 (m, 4H), 7.47-7.63 (m, 6H), 7.80-7.85 (m, 2H), 8.12 (m, 1H), 11.70 (s, 1H)
1 H-NMR:? 6.63-6.69 (m, 3H), 6.81-6.87 (m, 2H), 7.05 (m, 1H), 7.16-7.29 (m, 4H), 7.47-7.63 -7.85 (m, 2 H), 8.12 (m, 1 H), 11.70 (s, 1 H)
[준비예 5] IAz-5의 합성[Preparation Example 5] Synthesis of IAz-5
<단계 1> 7-(4-nitropyridin-3-yl)-9H-tribenzo[b,d,f]azepine의 합성<Step 1> Synthesis of 7- (4-nitropyridin-3-yl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (143 g, 387 mmol), 3-iodo-4-nitropyridine (96 g, 387 mmol) 및 Pd(PPh3)4 (22 g, 19 mmol)를 혼합한 다음, K2CO3 (160 g, 1161 mmol), 1,4-dioxane (1600 ml), H2O (400 ml)를 넣고서 110℃에서 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:1 (v/v))로 정제하여 7-(4-nitropyridin-3-yl)-9H-tribenzo[b,d,f]azepine (103 g, 수율 : 73 %)을 얻었다.B, d, f] azepine (143 g, 387 mmol), 3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- iodo-4-nitropyridine (96 g, 387 mmol) and Pd (PPh 3 ) 4 (22 g, 19 mmol) were mixed and then K 2 CO 3 (160 g, 1161 mmol), 1,4- ml) and H 2 O (400 ml) were added thereto, and the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the solvent was removed from the organic layer obtained by extraction with ethyl acetate and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain 7- (4-nitropyridin- -tribenzo [b, d, f] azepine (103 g, yield: 73%).
1H-NMR: δ 4.0 (s, 1H), 6.61-6.69 (m, 2H), 6.87-6.95 (m, 2H), 7.16 (m, 1H), 7.47-7.60 (m, 4H), 7.85-7.92 (m, 3H), 8.15 (m, 1H), 9.50 (m, 1H) 1 H-NMR:? 4.0 (s, 1H), 6.61-6.69 (m, 2H), 6.87-6.95 (m, 2H), 7.16 (m, 3 H), 8.15 (m, 1 H), 9.50 (m, 1 H)
<단계 2> 7-(4-nitropyridin-3-yl)-9-phenyl-9H-tribenzo[b,d,f]azepine 의 합성Synthesis of 7- (4-nitropyridin-3-yl) -9-phenyl-9H-tribenzo [b, d, f] azepine
질소 기류 하에서 7-(4-nitropyridin-3-yl)-9H-tribenzo[b,d,f]azepine (103 g. 281 mmol), iodobenzene (57 g, 281 mmol), Cu (8.9 g, 140 mmol), K2CO3 (116 g, 845 mmol) 및 nitrobenzene (990 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후, nitrobenzene을 제거하고 methylene chloride로 추출한 후 컬럼크로마토그래피 (Hexane : MC = 5:1 (v/v))로 정제하여 7-(4-nitropyridin-3-yl)-9-phenyl-9H-tribenzo[b,d,f]azepine (84 g, 수율 : 68%)을 얻었다.(103 g, 281 mmol), iodobenzene (57 g, 281 mmol), Cu (8.9 g, 140 mmol) in a stream of nitrogen were added to a solution of 7- (4-nitropyridin-3-yl) -9H- ), K 2 CO 3 (116 g, 845 mmol) and nitrobenzene (990 ml) were mixed and stirred at 190 ° C for 12 hours. After completion of the reaction, nitrobenzene was removed, and the residue was extracted with methylene chloride and then purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to obtain 7- (4-nitropyridin- -tribenzo [b, d, f] azepine (84 g, yield: 68%).
1H-NMR: δ 6.61-6.69 (m, 4H), 6.81-6.95 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.60 (m, 4H), 7.85-7.92 (m, 3H), 8.15 (m, 1H), 9.50 (m, 1H) 1 H-NMR: δ 6.61-6.69 ( m, 4H), 6.81-6.95 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.60 (m, 4H), 7.85-7.92 (m, 3H) , 8.15 (m, 1 H), 9.50 (m, 1 H)
<단계 3> IAz-5의 합성<Step 3> Synthesis of IAz-5
반응기에 7-(4-nitropyridin-3-yl)-9-phenyl-9H-tribenzo[b,d,f]azepine (84 g, 190 mmol), PPh3 (124 g, 475 mmol) 및 1,2-dichlorobenzene (880 ml)을 혼합 후, 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하고 컬럼크로마토그래피 (Hexane : MC = 2:1 (v/v))로 정제하여 IAz-5 (50 g, 수율 : 65 %)을 얻었다.(84 g, 190 mmol), PPh 3 (124 g, 475 mmol), and 1,2 (4-nitropyridin-3-yl) -9-phenyl-9H-tribenzo [ -dichlorobenzene (880 ml) were mixed and stirred for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate and purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain IAz-5 (50 g, yield 65%).
1H-NMR: δ 6.63-6.69 (m, 3H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 3H), 7.47-7.54 (m, 6H), 7.85 (m, 2H), 8.43 (m, 1H), 9.34 (m, 1H), 11.70 (s, 1H)
1 H-NMR: δ 6.63-6.69 ( m, 3H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 3H), 7.47-7.54 (m, 6H), 7.85 (m, 2H), 8.43 (m, 1 H), 9.34 (m, 1 H), 11.70 (s, 1 H)
[준비예 6] IAz-6"의 합성[Preparation Example 6] Synthesis of IAz-6 "
<단계 1> 7-(5-chloro-2-nitrophenyl)-9H-tribenzo[b,d,f]azepine의 합성<Step 1> Synthesis of 7- (5-chloro-2-nitrophenyl) -9H-tribenzo [b, d, f] azepine
질소 기류 하에서 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-tribenzo[b,d,f]azepine (147 g, 398 mmol), 4-chloro-2-iodo-1-nitrobenzene (112 g, 398 mmol) 및 Pd(PPh3)4 (23 g, 19 mmol)를 혼합한 다음, K2CO3 (165 g, 1194 mmol), 1,4-dioxane (1600 ml), H2O (400 ml)를 넣고서 110℃에서 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:1 (v/v))로 정제하여 7-(5-chloro-2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (112 g, 수율 : 71 %)을 얻었다.(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -9H-tribenzo [b, d, f] azepine (147 g, 398 mmol) chloro-2-iodo-1- nitrobenzene (112 g, 398 mmol) and Pd (PPh 3) 4 (23 g, 19 mmol) were mixed, and then, K 2 CO 3 (165 g , 1194 mmol), 1,4 -dioxane (1600 ml) and H 2 O (400 ml) were placed, and the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the solvent was removed from the organic layer obtained by extraction with ethyl acetate, and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain 7- (5-chloro-2-nitrophenyl) -tribenzo [b, d, f] azepine (112 g, yield: 71%).
1H-NMR: δ 4.0 (s, 1H), 6.61-6.69 (m, 2H), 6.87-6.95 (m, 2H), 7.16 (m, 1H), 7.47-7.60 (m, 4H), 7.71 (m, 1H) 7.85 (m, 2H), 8.26-8.27 (m, 2H) 1 H-NMR: δ 4.0 ( s, 1H), 6.61-6.69 (m, 2H), 6.87-6.95 (m, 2H), 7.16 (m, 1H), 7.47-7.60 (m, 4H), 7.71 (m , ≪ / RTI > 1H) 7.85 (m, 2H), 8.26-8.27 (m, 2H)
<단계 2> 7-(5-chloro-2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine의 합성Step 2 Synthesis of 7- (5-chloro-2-nitrophenyl) -9-phenyl-9H-tribenzo [b, d, f] azepine
질소 기류 하에서 7-(5-chloro-2-nitrophenyl)-9H-tribenzo[b,d,f]azepine (112 g. 280 mmol), iodobenzene(57 g, 280 mmol), Cu (8.9 g, 140 mmol), K2CO3 (116 g, 842 mmol) 및 nitrobenzene (990 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후, nitrobenzene을 제거하고 methylene chloride로 추출한 후 컬럼크로마토그래피 (Hexane : MC = 5:1 (v/v))로 정제하여 7-(5-chloro-2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (92 g, 수율 : 69%)을 얻었다.(112 g, 280 mmol), iodobenzene (57 g, 280 mmol) and Cu (8.9 g, 140 mmol) in a stream of nitrogen were added to a solution of 7- (5-chloro-2- nitrophenyl) -9H- ), K 2 CO 3 (116 g, 842 mmol) and nitrobenzene (990 ml) were mixed and stirred at 190 ° C for 12 hours. After completion of the reaction, nitrobenzene was removed, and the residue was extracted with methylene chloride. The residue was purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to obtain 7- (5-chloro-2-nitrophenyl) -tribenzo [b, d, f] azepine (92 g, yield 69%).
1H-NMR: δ 6.61-6.69 (m, 4H), 6.81-6.95 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.60 (m, 4H), 7.71 (m, 1H), 7.85 (m, 2H), 8.26-8.27 (m, 2H) 1 H-NMR:? 6.61-6.69 (m, 4H), 6.81-6.95 (m, 3H), 7.16-7.20 (m, 3H), 7.47-7.60 (m, 2 H), 8.26 - 8.27 (m, 2 H)
<단계 3>IAz-6의 합성<Step 3> Synthesis of IAz-6
반응기에 7-(5-chloro-2-nitrophenyl)-9-phenyl-9H-tribenzo[b,d,f]azepine (92 g, 193 mmol), PPh3 (127 g, 484 mmol) 및 1,2-dichlorobenzene (880 ml)을 혼합 후, 12시간 동안 교반하였다. 반응 종결 후 ethyl acetate로 추출하고 컬럼크로마토그래피 (Hexane : MC = 2:1 (v/v))로 정제하여 IAz-6 (58 g, 수율 : 68 %)을 얻었다.(92 g, 193 mmol), PPh 3 (127 g, 484 mmol), and 1,2 (2-chloro-2-nitrophenyl) -9- -dichlorobenzene (880 ml) were mixed and stirred for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate and purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain IAz-6 (58 g, yield 68%).
1H-NMR: δ 6.63-6.69 (m, 3H), 6.81-6.87 (m, 2H), 7.09-7.29 (m, 4H), 7.47-7.57 (m, 6H), 7.85 (m, 2H), 11.70 (s, 1H) 1 H-NMR: δ 6.63-6.69 ( m, 3H), 6.81-6.87 (m, 2H), 7.09-7.29 (m, 4H), 7.47-7.57 (m, 6H), 7.85 (m, 2H), 11.70 (s, 1 H)
<단계 4> IAz-6'의 합성<Step 4> Synthesis of IAz-6 '
질소 기류 하에서 IAz-6 (58 g, 130 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150 g, 594 mmol), Pd(dppf)Cl2 (36 g, 144 mmol), KOAc (36 g, 392.0 mmol) 및 1,4-dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응 종결 후, methylene chloride로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:2 (v/v))로 정제하여 IAz-6'(51 g, 수율 : 73 %)을 얻었다.(58 g, 130 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane ) (150 g, 594 mmol) , Pd (dppf) Cl 2 (36 g, 144 mmol), KOAc (36 g, 392.0 mmol) and a mixture of 1,4-dioxane (500 ml) for 12 hours and at 130 ℃ Lt; / RTI > After completion of the reaction, the solvent was removed from the organic layer obtained by extraction with methylene chloride, and the residue was purified by column chromatography (Hexane: MC = 3: 2 (v / v)) to obtain IAz-6 '(51 g, yield: 73% ≪ / RTI >
1H-NMR: δ 1.24 (s, 12H), 6.63-6.69 (m, 3H), 6.81-6.87 (m, 3H), 7.10-7.20 (m, 4H), 7.47-7.54 (m, 6H), 7.85 (m, 2H), 11.70 (s, 1H) 1 H-NMR:? 1.24 (s, 12H), 6.63-6.69 (m, 3H), 6.81-6.87 (m, 3H), 7.10-7.20 (m, 4H), 7.47-7.54 (m, 2 H), 11.70 (s, 1 H)
<단계 5> IAz-6"의 합성<Step 5> Synthesis of IAz-6
질소 기류 하에서 IAz-6'(51 g, 95 mmol), 2-bromo-4,6-diphenylbenzene (29 g, 95 mmol) 및 Pd(PPh3)4 (5.5 g, 4.7 mmol)를 혼합한 다음, K2CO3 (40 g, 286 mmol), 1,4-dioxane (800 ml), H2O (200 ml)를 넣고서 110℃에서 12시간 동안 교반하였다. 반응 종결 후, ethyl acetate로 추출하여 수득한 유기층에서 용매를 제거하고 컬럼크로마토그래피 (Hexane : MC = 3:1 (v/v))로 정제하여 IAz-6"(44 g, 수율 : 74 %) 을 얻었다.(51 g, 95 mmol), 2-bromo-4,6-diphenylbenzene (29 g, 95 mmol) and Pd (PPh 3 ) 4 (5.5 g, 4.7 mmol) were mixed in a nitrogen stream, K 2 CO 3 (40 g, 286 mmol), 1,4-dioxane (800 ml) and H 2 O (200 ml) were placed and stirred at 110 ° C for 12 hours. After completion of the reaction, the solvent was removed from the organic layer obtained by extraction with ethyl acetate, and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain IAz-6 "(44 g, yield: 74% ≪ / RTI >
1H-NMR: δ 6.63-6.69 (m, 3H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 3H), 7.41-7.54 (m, 15H), 7.66-7.69 (m, 3H), 7.85-7.87 (m, 3H), 11.70 (s, 1H)
1 H-NMR: δ 6.63-6.69 ( m, 3H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 3H), 7.41-7.54 (m, 15H), 7.66-7.69 (m, 3H) , 7.85-7.87 (m, 3H), 11.70 (s, 1 H)
[합성예 1] 화합물 1-1의 합성[Synthesis Example 1] Synthesis of Compound 1-1
질소 기류 하에서 IAz-1 (2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline (0.2 g, 1.2 mmol), Cs2CO3 (3.9 g, 12 mmol) 및 nitrobenzene (30 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 화합물 1-1 (2.7 g, 수율 70 %)을 얻었다.(2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (3.9 g, 12 mmol) and nitrobenzene (30 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain Compound 1-1 (2.7 g, yield 70%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 2] 화합물 1-2의 합성[Synthesis Example 2] Synthesis of Compound 1-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-2 (2.8 g, 수율 72 %)를 얻었다.The same procedure as in Synthesis Example 1 was carried out except that 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 1-2 (2.8 g, Yield: 72%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 3] 화합물 1-3의 합성[Synthesis Example 3] Synthesis of Compound 1-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-3 (2.9 g, 수율 73 %)을 얻었다.The same procedure as in Synthesis Example 1 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine Compound 1-3 (2.9 g, yield 73%) was obtained.
Mass (이론치: 639.24, 측정치: 639 g/mol)
Mass (theory: 639.24, found: 639 g / mol)
[합성예 4] 화합물 1-4의 합성[Synthesis Example 4] Synthesis of Compound 1-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-4 (3.0 g, 수율 69 %)를 얻었다.Except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was carried out to obtain Compound 1-4 (3.0 g, yield 69%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 5] 화합물 1-5의 합성[Synthesis Example 5] Synthesis of Compound 1-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-5 (2.9 g, 수율 67 %)를 얻었다.(3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was performed to obtain Compound 1-5 (2.9 g, yield 67%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 6] 화합물 1-6의 합성[Synthesis Example 6] Synthesis of Compound 1-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene ( 2.5 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-6 (2.7 g, 수율 65 %)을 얻었다.The same procedure as in Synthesis Example 1 was carried out except that 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.5 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine, 6 (2.7 g, yield 65%).
Mass (이론치: 666.21, 측정치: 666 g/mol)
Mass (theory: 666.21, found: 666 g / mol)
[합성예 7] 화합물 1-7의 합성[Synthesis Example 7] Synthesis of Compound 1-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-7 (2.5 g, 수율 72 %)을 얻었다.The same procedure as in Synthesis Example 1 was carried out except that 2-bromodibenzo [b, d] furan (1.8 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 1-7 Yield: 72%).
Mass (이론치: 574.20, 측정치: 574 g/mol)
Mass (theory: 574.20, measurement: 574 g / mol)
[합성예 8] 화합물 1-8의 합성[Synthesis Example 8] Synthesis of Compound 1-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-8 (2.9 g, 수율 68 %)을 얻었다.The procedure of Synthesis Example 1 was repeated except that 2- (4-bromophenyl) triphenylene (2.8 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 1-8 68%).
Mass (이론치: 710.27, 측정치: 710 g/mol)
Mass (theory: 710.27, measurement: 710 g / mol)
[합성예 9] 화합물 1-9의 합성[Synthesis Example 9] Synthesis of Compound 1-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-9 (2.8 g, 수율 75 %)을 얻었다.The procedure of Synthesis Example 1 was repeated except that 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 1-9 (2.8 g, yield 75 %).
Mass (이론치: 612.23, 측정치: 612 g/mol)
Mass (theory: 612.23, measurement: 612 g / mol)
[합성예 10] 화합물 1-10의 합성[Synthesis Example 10] Synthesis of Compound 1-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.7 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 화합물 1-10 (3.3 g, 수율 72 %)을 얻었다.The same procedure as in Synthesis Example 1 was performed except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.7 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 1-10 (3.3 g, yield 72%).
Mass (이론치: 738.28, 측정치: 738 g/mol)
Mass (theory: 738.28, found: 738 g / mol)
[합성예 11] 화합물 1-11의 합성[Synthesis Example 11] Synthesis of Compound 1-11
질소 기류 하에서 IAz-2 (2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline (0.2 g, 1.2 mmol), Cs2CO3 (3.9 g, 12 mmol) 및 nitrobenzene (30 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 화합물 1-11 (2.8 g, 수율 72 %)을 얻었다.(2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (3.9 g, 12 mmol) and nitrobenzene (30 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain Compound 1-11 (2.8 g, yield 72%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 12] 화합물 1-12의 합성[Synthesis Example 12] Synthesis of Compound 1-12
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-12 (2.8 g, 수율 71 %)를 얻었다.The compound 1-12 (2.8 g, 7.3 mmol) was treated in the same manner as in Synthesis Example 11, except that 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine. Yield: 71%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 13] 화합물 1-13의 합성[Synthesis Example 13] Synthesis of Compound 1-13
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-13 (2.9 g, 수율 74 %)을 얻었다.The procedure was the same as that of Synthesis Example 11 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine Compound 1-13 (2.9 g, yield 74%) was obtained.
Mass (이론치: 639.24, 측정치: 639 g/mol)
Mass (theory: 639.24, found: 639 g / mol)
[합성예14] 화합물 1-14의 합성[Synthesis Example 14] Synthesis of Compound 1-14
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-14 (3.2 g, 수율 74 %)를 얻었다.Except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.8 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was performed to obtain Compound 1-14 (3.2 g, yield 74%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 15] 화합물 1-15의 합성[Synthesis Example 15] Synthesis of Compound 1-15
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-15 (3.0 g, 수율 69 %)를 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was performed to obtain Compound 1-15 (3.0 g, yield 69%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 16] 화합물 1-16의 합성[Synthesis Example 16] Synthesis of Compound 1-16
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (2.5 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-16 (2.6 g, 수율 65 %)을 얻었다.The same procedure as in Synthesis Example 11 was carried out except that 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.5 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine, 16 (2.6 g, yield 65%).
Mass (이론치: 666.21, 측정치: 666 g/mol)
Mass (theory: 666.21, found: 666 g / mol)
[합성예 17] 화합물 1-17의 합성[Synthesis Example 17] Synthesis of Compound 1-17
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-17 (2.5 g, 수율 71 %)을 얻었다.The same procedure as in Synthesis Example 11 was carried out except that 2-bromodibenzo [b, d] furan (1.8 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 1-17 Yield: 71%).
Mass (이론치: 590.18, 측정치: 590 g/mol)
Mass (theory: 590.18, measurement: 590 g / mol)
[합성예 18] 화합물 1-18의 합성[Synthesis Example 18] Synthesis of Compound 1-18
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-18 (3.1 g, 수율 73 %)을 얻었다.The same procedure as in Synthesis Example 11 was carried out except that 2- (4-bromophenyl) triphenylene (2.8 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 1-18 73%).
Mass (이론치: 710.27, 측정치: 710 g/mol)
Mass (theory: 710.27, measurement: 710 g / mol)
[합성예 19] 화합물 1-19의 합성[Synthesis Example 19] Synthesis of Compound 1-19
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-19 (2.3 g, 수율 73 %)을 얻었다.The procedure of Synthesis Example 11 was repeated except that 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 1-19 %).
Mass (이론치: 612.23, 측정치: 612 g/mol)
Mass (theory: 612.23, measurement: 612 g / mol)
[합성예 20] 화합물 1-20의 합성[Synthesis Example 20] Synthesis of Compound 1-20
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.7 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 화합물 1-20 (3.4 g, 수율 75 %)을 얻었다.The same procedure as in Synthesis Example 11 was performed except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.7 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 1-20 (3.4 g, yield 75%).
Mass (이론치: 738.28, 측정치: 738 g/mol)
Mass (theory: 738.28, found: 738 g / mol)
[합성예 21] 화합물 2-1의 합성[Synthesis Example 21] Synthesis of Compound 2-1
질소 기류 하에서 IAz-3 (2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline (0.2 g, 1.2 mmol), Cs2CO3 (3.9 g, 12 mmol) 및 nitrobenzene (30 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 화합물 2-1 (2.9 g, 수율 76 %)을 얻었다.(2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (3.9 g, 12 mmol) and nitrobenzene (30 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain Compound 2-1 (2.9 g, yield 76%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 22] 화합물 2-2의 합성[Synthesis Example 22] Synthesis of Compound 2-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-2 (2.8 g, 수율 72 %)를 얻었다.2-2 (2.8 g, 7.3 mmol) was obtained by following the same procedure as in Synthesis Example 21, except that 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. Yield: 72%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 23] 화합물 2-3의 합성[Synthesis Example 23] Synthesis of Compound 2-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-3 (2.8 g, 수율 72 %)을 얻었다.The same procedure as in Synthesis Example 21 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine Compound 2-3 (2.8 g, yield 72%) was obtained.
Mass (이론치: 639.24, 측정치: 639 g/mol)
Mass (theory: 639.24, found: 639 g / mol)
[합성예 24] 화합물 2-4의 합성[Synthesis Example 24] Synthesis of Compound 2-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-4 (3.0 g, 수율 69 %)를 얻었다.Except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.8 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was performed to obtain Compound 2-4 (3.0 g, yield 69%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 25] 화합물 2-5의 합성[Synthesis Example 25] Synthesis of Compound 2-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-5 (2.8 g, 수율 66 %)를 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 2-5 (2.8 g, yield 66%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 26] 화합물 2-6의 합성[Synthesis Example 26] Synthesis of Compound 2-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (2.5 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-6 (2.6 g, 수율 66 %)을 얻었다.The procedure of Synthetic Example 21 was repeated except that 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.5 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain 2- 6 (2.6 g, yield 66%).
Mass (이론치: 666.21, 측정치: 666 g/mol)
Mass (theory: 666.21, found: 666 g / mol)
[합성예 27] 화합물 2-7의 합성[Synthesis Example 27] Synthesis of Compound 2-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-7 (2.4 g, 수율 70 %)을 얻었다.The same procedure as in Synthesis Example 21 was carried out except that 2-bromodibenzo [b, d] furan (1.8 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine, Yield: 70%).
Mass (이론치: 574.20, 측정치: 574 g/mol)
Mass (theory: 574.20, measurement: 574 g / mol)
[합성예 28] 화합물 2-8의 합성[Synthesis Example 28] Synthesis of Compound 2-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-8 (3.2 g, 수율 74 %)을 얻었다.The same procedure as in Synthesis Example 21 was repeated but using 2- (4-bromophenyl) triphenylene (2.8 g, 7.3 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 2-8 74%).
Mass (이론치: 710.27, 측정치: 710 g/mol)
Mass (theory: 710.27, measurement: 710 g / mol)
[합성예 29] 화합물 2-9의 합성[Synthesis Example 29] Synthesis of Compound 2-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-9 (2.6 g, 수율 72 %)을 얻었다.(2.6 g, yield 72%) was obtained by following the same procedure as in Synthesis Example 21, except that 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine. %).
Mass (이론치: 612.23, 측정치: 612 g/mol)
Mass (theory: 612.23, measurement: 612 g / mol)
[합성예 30] 화합물 2-10의 합성[Synthesis Example 30] Synthesis of Compound 2-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.7 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 화합물 2-10 (3.1 g, 수율 70 %)을 얻었다.The same procedure as in Synthesis Example 21 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.7 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 2-10 (3.1 g, yield 70%).
Mass (이론치: 738.28, 측정치: 738 g/mol)
Mass (theory: 738.28, found: 738 g / mol)
[합성예 31] 화합물 3-1의 합성[Synthesis Example 31] Synthesis of Compound 3-1
질소 기류 하에서 IAz-4 (2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline (0.2 g, 1.2 mmol), Cs2CO3 (3.9 g, 12 mmol) 및 nitrobenzene (30 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 화합물 3-1 (2.8 g, 수율 72 %)을 얻었다.(2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (3.9 g, 12 mmol) and nitrobenzene (30 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain Compound 3-1 (2.8 g, yield 72%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 32] 화합물 3-2의 합성[Synthesis Example 32] Synthesis of Compound 3-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-2 (2.7 g, 수율 70 %)를 얻었다.The same procedure as in Synthesis Example 31 was repeated but using 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 3-2 Yield: 70%).
Mass (이론치: 638.25, 측정치: 638 g/mol)
Mass (theory: 638.25, measurement: 638 g / mol)
[합성예 33] 화합물 3-3의 합성[Synthesis Example 33] Synthesis of Compound 3-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-3 (2.6 g, 수율 67 %)을 얻었다.The same procedure was followed as in Synthesis 31 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine Compound 3-3 (2.6 g, yield 67%) was obtained.
Mass (이론치: 639.24, 측정치: 639 g/mol)
Mass (theory: 639.24, found: 639 g / mol)
[합성예 34] 화합물 3-4의 합성[Synthesis Example 34] Synthesis of Compound 3-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-4 (3.0 g, 수율 69 %)를 얻었다.Except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was performed to obtain Compound 3-4 (3.0 g, yield 69%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 35] 화합물 3-5의 합성[Synthesis Example 35] Synthesis of Compound 3-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-5 (2.6 g, 수율 66 %)를 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 3-5 (2.6 g, yield 66%).
Mass (이론치: 715.27, 측정치: 715 g/mol)
Mass (theory: 715.27, found: 715 g / mol)
[합성예 36] 화합물 3-6의 합성[Synthesis Example 36] Synthesis of Compound 3-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene ( 2.4 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-6 (2.9 g, 수율 71 %)을 얻었다.The procedure of Synthesis Example 31 was repeated except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.4 g, 7.3 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain 3- 6 (2.9 g, yield 71%).
Mass (이론치: 666.21, 측정치: 666 g/mol)
Mass (theory: 666.21, found: 666 g / mol)
[합성예 37] 화합물 3-7의 합성[Synthesis Example 37] Synthesis of Compound 3-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-7 (2.5 g, 수율 73 %)을 얻었다.The same procedure as in Synthesis Example 31 was repeated but using 2-bromodibenzo [b, d] furan (1.8 g, 7.3 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain 3- Yield: 73%).
Mass (이론치: 574.20, 측정치: 574 g/mol)
Mass (theory: 574.20, measurement: 574 g / mol)
[합성예 38] 화합물 3-8의 합성[Synthesis Example 38] Synthesis of Compound 3-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-8 (3.2 g, 수율 74 %)을 얻었다.The same procedure as in Synthesis Example 31 was repeated, except that 2- (4-bromophenyl) triphenylene (2.8 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine to obtain 3-8 74%).
Mass (이론치: 710.27, 측정치: 710 g/mol)
Mass (theory: 710.27, measurement: 710 g / mol)
[합성예 39] 화합물 3-9의 합성[Synthesis Example 39] Synthesis of Compound 3-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-9 (2.7 g, 수율 74 %)을 얻었다.(2.7 g, yield 74%) was obtained by following the same procedure as in Synthesis 31 except that 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine. %).
Mass (이론치: 612.23, 측정치: 612 g/mol)
Mass (theory: 612.23, measurement: 612 g / mol)
[합성예 40] 화합물 3-10의 합성[Synthesis Example 40] Synthesis of Compound 3-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.7 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 화합물 3-10 (3.0 g, 수율 68 %)을 얻었다.The same procedure as in Synthesis Example 31 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.7 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 3-10 (3.0 g, yield 68%).
Mass (이론치: 738.28, 측정치: 738 g/mol)
Mass (theory: 738.28, found: 738 g / mol)
[합성예 41] 화합물 4-1의 합성[Synthesis Example 41] Synthesis of Compound 4-1
질소 기류 하에서 IAz-5 (2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.2 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline (0.2 g, 1.2 mmol), Cs2CO3 (3.9 g, 12 mmol) 및 nitrobenzene (30 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 화합물 4-1 (2.6 g, 수율 68 %)을 얻었다.(2.5 g, 6.1 mmol), 2-bromo-4,6-diphenylpyrimidine (2.2 g, 7.3 mmol), CuI (0.1 g, 0.61 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (3.9 g, 12 mmol) and nitrobenzene (30 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain Compound 4-1 (2.6 g, yield 68%).
Mass (이론치: 639.24, 측정치: 639 g/mol)
Mass (theory: 639.24, found: 639 g / mol)
[합성예 42] 화합물 4-2의 합성[Synthesis Example 42] Synthesis of Compound 4-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-2 (2.8 g, 수율 72 %)를 얻었다.Compound 4-2 (2.8 g, 7.3 mmol) was obtained by following the same procedure as Synthesis Example 41, except that 4-bromo-2,6-diphenylpyrimidine (2.3 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. Yield: 72%).
Mass (이론치: 639.24, 측정치: 639 g/mol)
Mass (theory: 639.24, found: 639 g / mol)
[합성예 43] 화합물 4-3의 합성[Synthesis Example 43] Synthesis of Compound 4-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-3 (2.7 g, 수율 69 %)을 얻었다.The procedure of Synthesis Example 41 was repeated except that 2-chloro-4,6-diphenyl-1,3,5-triazine (1.9 g, 7.3 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine Compound 4-3 (2.7 g, yield 69%) was obtained.
Mass (이론치: 640.24, 측정치: 640 g/mol)
Mass (theory: 640.24, measured: 640 g / mol)
[합성예 44] 화합물 4-4의 합성[Synthesis Example 44] Synthesis of Compound 4-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-4 (2.9 g, 수율 68 %)를 얻었다.Was prepared in the same manner as in Synthesis Example 41, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.8 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine. Was performed to obtain compound 4-4 (2.9 g, yield 68%).
Mass (이론치: 716.27, 측정치: 716 g/mol)
Mass (theory: 716.27, measurement: 716 g / mol)
[합성예 45] 화합물 4-5의 합성[Synthesis Example 45] Synthesis of Compound 4-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-5 (3.0 g, 수율70 %)를 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.9 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was performed to obtain Compound 4-5 (3.0 g, yield 70%).
Mass (이론치: 716.27, 측정치: 716 g/mol)
Mass (theory: 716.27, measurement: 716 g / mol)
[합성예 46] 화합물 4-6의 합성[Synthesis Example 46] Synthesis of Compound 4-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (2.5 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-6 (2.6 g, 수율 65 %)을 얻었다.The same procedure as in Synthesis Example 41 was carried out except that 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.5 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine, 6 (2.6 g, yield 65%).
Mass (이론치: 667.21, 측정치: 667 g/mol)
Mass (calc .: 667.21, found: 667 g / mol)
[합성예 47] 화합물 4-7의 합성[Synthesis Example 47] Synthesis of Compound 4-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-7 (2.6 g, 수율 74 %)을 얻었다.The same procedure as in Synthesis Example 41 was repeated but using 2-bromodibenzo [b, d] furan (1.8 g, 7.3 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 4-7 Yield: 74%).
Mass (이론치: 575.20, 측정치: 575 g/mol)
Mass (theory: 575.20, measurement: 575 g / mol)
[합성예 48] 화합물 4-8의 합성[Synthesis Example 48] Synthesis of Compound 4-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (2.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-8 (3.0 g, 수율 71 %)을 얻었다.The same procedure as in Synthesis Example 41 was repeated but using 2- (4-bromophenyl) triphenylene (2.8 g, 7.3 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain 4- 71%).
Mass (이론치: 711.27, 측정치: 711 g/mol)
Mass (theory: 711.27, measurement: 711 g / mol)
[합성예 49] 화합물 4-9의 합성[Synthesis Example 49] Synthesis of Compound 4-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-9 (2.7 g, 수율 73 %)을 얻었다.The same procedure as in Synthesis Example 41 was repeated but using 2-chloro-4-phenylquinazoline (1.8 g, 7.3 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 4-9 (2.7 g, yield 73 %).
Mass (이론치: 613.23, 측정치: 613 g/mol)
Mass (theory: 613.23, measured: 613 g / mol)
[합성예 50] 화합물 4-10의 합성[Synthesis Example 50] Synthesis of Compound 4-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.7 g, 7.3 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 화합물 4-10 (3.2 g, 수율 72 %)을 얻었다.The same procedure as in Synthesis Example 41 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.7 g, 7.3 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 4-10 (3.2 g, yield 72%).
Mass (이론치: 739.27, 측정치: 739 g/mol)
Mass (theory: 739.27, found: 739 g / mol)
[합성예 51] 화합물 5-1의 합성[Synthesis Example 51] Synthesis of Compound 5-1
질소 기류 하에서 IAz-6" (2.5 g, 3.9 mmol), 2-bromo-4,6-diphenylpyrimidine (1.4 g, 4.7 mmol), CuI (0.1 g, 0.39 mmol), 1,10-phenanthroline (0.1 g, 0.78 mmol), Cs2CO3 (2.5 g, 7.8 mmol) 및 nitrobenzene (30 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 화합물 5-1 (2.4 g, 수율 70 %)을 얻었다.2-bromo-4,6-diphenylpyrimidine (1.4 g, 4.7 mmol), CuI (0.1 g, 0.39 mmol), 1,10-phenanthroline (0.1 g, 0.78 mmol), Cs 2 CO 3 (2.5 g, 7.8 mmol) and nitrobenzene (30 ml) were mixed and stirred for 3 hours at 210 ° C. After completion of the reaction, the solid salt was filtered and purified by column chromatography To obtain Compound 5-1 (2.4 g, yield 70%).
Mass (이론치: 866.34, 측정치: 866 g/mol)
Mass (theory: 866.34, measurement: 866 g / mol)
[합성예 52] 화합물 5-2의 합성[Synthesis Example 52] Synthesis of Compound 5-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (1.4 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-2 (2.3 g, 수율 68 %)를 얻었다.The same procedure as in Preparation Example 51 was repeated but using 4-bromo-2,6-diphenylpyrimidine (1.4 g, 4.7 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 5-2 Yield: 68%).
Mass (이론치: 866.34, 측정치: 866 g/mol)
Mass (theory: 866.34, measurement: 866 g / mol)
[합성예 53] 화합물 5-3의 합성[Synthesis Example 53] Synthesis of Compound 5-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (1.2 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-3 (2.5 g, 수율 74 %)을 얻었다.The same procedure as in Preparation Example 51 was performed except that 2-chloro-4,6-diphenyl-1,3,5-triazine (1.2 g, 4.7 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine Compound 5-3 (2.5 g, yield 74%) was obtained.
Mass (이론치: 867.34, 측정치: 867 g/mol)
Mass (theory: 867.34, measurement: 867 g / mol)
[합성예 54] 화합물 5-4의 합성[Synthesis Example 54] Synthesis of Compound 5-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (1.8 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-4 (2.6 g, 수율 71 %)를 얻었다.Except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (1.8 g, 4.7 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 5-4 (2.6 g, yield 71%).
Mass (이론치: 943.37, 측정치: 943 g/mol)
Mass (theory: 943.37, measurement: 943 g / mol)
[합성예 55] 화합물 5-5의 합성[Synthesis Example 55] Synthesis of Compound 5-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (1.8 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-5 (2.5 g, 수율 70 %)를 얻었다.The same procedure as in Preparation Example 51 was repeated, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (1.8 g, 4.7 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine Was performed to obtain Compound 5-5 (2.5 g, yield 70%).
Mass (이론치: 943.37, 측정치: 943 g/mol)
Mass (theory: 943.37, measurement: 943 g / mol)
[합성예 56] 화합물 5-6의 합성[Synthesis Example 56] Synthesis of Compound 5-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene ( 1.6 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-6 (2.4 g, 수율 67 %)을 얻었다.The same procedure as in Preparation Example 51 was repeated but using 2- (3-bromophenyl) dibenzo [b, d] thiophene (1.6 g, 4.7 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, 6 (2.4 g, yield 67%).
Mass (이론치: 894.31, 측정치: 894 g/mol)
Mass (theory: 894.31, measurement: 894 g / mol)
[합성예 57] 화합물 5-7의 합성[Synthesis Example 57] Synthesis of Compound 5-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.2 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-7 (2.2 g, 수율 69 %)을 얻었다.The same procedure as in Preparation Example 51 was repeated but using 2-bromodibenzo [b, d] furan (1.2 g, 4.7 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 5-7 Yield: 69%).
Mass (이론치: 802.30, 측정치: 802 g/mol)
Mass (theory: 802.30, measured: 802 g / mol)
[합성예 58] 화합물 5-8의 합성[Synthesis Example 58] Synthesis of Compound 5-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (1.8 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-8 (2.6 g, 수율 72 %)을 얻었다.The same procedure as in Preparation Example 51 was repeated but using 2- (4-bromophenyl) triphenylene (1.8 g, 4.7 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain Compound 5-8 72%).
Mass (이론치: 938.37, 측정치: 938 g/mol)
Mass (theory: 938.37, measured: 938 g / mol)
[합성예 59] 화합물 5-9의 합성[Synthesis Example 59] Synthesis of Compound 5-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.1 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-9 (2.4 g, 수율 74 840.33%)을 얻었다.The same procedure as in Synthesis Example 51 was repeated but using 2-chloro-4-phenylquinazoline (1.1 g, 4.7 mmol) instead of 2-bromo-4,6-diphenylpyrimidine to obtain the compound 5-9 (2.4 g, yield 74 840.33%).
Mass (이론치: 측정치: 840 g/mol)
Mass (theory: measured: 840 g / mol)
[합성예 60] 화합물 5-10의 합성[Synthesis Example 60] Synthesis of Compound 5-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (1.7 g, 4.7 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 화합물 5-10 (2.8 g, 수율 75 %)을 얻었다.The same procedure as in Synthesis Example 51 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (1.7 g, 4.7 mmol) was used in place of 2-bromo-4,6-diphenylpyrimidine To obtain Compound 5-10 (2.8 g, yield 75%).
Mass (이론치: 966.37, 측정치: 966 g/mol)
Mass (theory: 966.37, found: 966 g / mol)
[실시예 1 내지 48] 녹색 유기 전계 발광 소자의 제조[Examples 1 to 48] Preparation of green organic electroluminescent device
합성예에서 합성한 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 전계 발광 소자를 제조하였다.The compound synthesized in Synthesis Example was subjected to high purity sublimation purification by a conventionally known method, and then a green organic electroluminescent device was manufactured according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium Tin Oxide) with a thickness of 1500 Å was ultrasonically washed with distilled water. After the distilled water was washed, the substrate was ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, and methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.
이렇게 준비된 ITO 투명 기판(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ 90% 하기 표 1의 호스트 화합물 + 10 % Ir(ppy)3 (30nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 소자를 제조하였다.
M-MTDATA (60 nm) / TCTA (80 nm) / 90% on the prepared ITO transparent substrate (electrode) + 10% Ir (ppy) 3 (30 nm) / BCP 3 (30 nm) / LiF (1 nm) / Al (200 nm) in this order.
[비교예 1] 녹색 유기 전계 발광 소자의 제조[Comparative Example 1] Production of green organic electroluminescent device
발광층 형성시 발광 호스트 물질로서 화합물 1-1 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제조하였다.
A green organic electroluminescent device was fabricated in the same manner as in Example 1, except that CBP was used instead of Compound 1-1 as a luminescent host material in forming the light emitting layer.
상기 실시예 1 내지 48 및 비교예 2에서 사용된 m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , CBP and BCP used in Examples 1 to 48 and Comparative Example 2 are as follows.
[평가예 1][Evaluation Example 1]
실시예 1 내지 48 및 비교예 1에서 제조한 녹색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.The driving voltage, current efficiency and emission peak at a current density of 10 mA / cm 2 were measured for the green organic electroluminescent devices manufactured in Examples 1 to 48 and Comparative Example 1, and the results are shown in Table 1 below.
상기 표1에 나타낸 바와 같이, 본 발명의 화합물을 녹색 유기 전계 발광 소자의 발광층에 사용한 경우(실시예 1내지 48)가 종래 CBP를 녹색 유기 전계 발광 소자의 발광층에 사용한 경우(비교예1)보다 효율 및 구동전압이 우수한 것을 확인할 수 있었다.
As shown in Table 1, when the compound of the present invention was used for the light emitting layer of the green organic electroluminescent device (Examples 1 to 48), the conventional CBP was used for the light emitting layer of the green organic electroluminescent device (Comparative Example 1) It was confirmed that the efficiency and the driving voltage were excellent.
[실시예 49 내지 60] 적색 유기 전계 발광 소자의 제조[Examples 49 to 60] Preparation of red organic electroluminescent device
합성예에서 합성한 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 적색 유기 전계 발광 소자를 제조하였다.The compound synthesized in Synthesis Example was subjected to high purity sublimation purification by a conventionally known method, and then a red organic electroluminescent device was manufactured according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium Tin Oxide) with a thickness of 1500 Å was ultrasonically washed with distilled water. After the distilled water was washed, the substrate was ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, and methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.
이렇게 준비된 ITO 투명 기핀(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm) / 90% 하기 표 2 의 호스트 화합물 + 10 % (piq)2Ir(acac) (30nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 소자를 제조하였다.
M-MTDATA (60 nm) / TCTA (80 nm) / 90% on the prepared ITO transparent pin (electrode) + host compound + 10% (piq) 2 Ir (acac) (30 nm) / BCP ) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) in this order.
[비교예 2][Comparative Example 2]
발광층 형성시 발광 호스트 물질로서 화합물 1-9 대신 CBP를 사용하는 것을 제외하고는 실시예 49와 동일한 과정으로 적색 유기 전계 발광 소자를 제조하였다.
A red organic electroluminescent device was fabricated in the same manner as in Example 49, except that CBP was used instead of Compound 1-9 as a luminescent host material in forming the light emitting layer.
상기 실시예 49 내지 60 및 비교예 2에서 사용된 m-MTDATA, TCTA, CBP 및 BCP의 구조는 상기와 같으며, (piq)2Ir(acac)의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, CBP and BCP used in Examples 49 to 60 and Comparative Example 2 are as described above, and the structure of (piq) 2 Ir (acac) is as follows.
[평가예 2][Evaluation Example 2]
실시예 49 내지 60 및 비교예 2에서 제조한 적색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율을 측정하고, 그 결과를 하기 표 2에 나타내었다.The driving voltage and current efficiency at the current density of 10 mA / cm 2 were measured for the red organic electroluminescent devices prepared in Examples 49 to 60 and Comparative Example 2, and the results are shown in Table 2 below.
상기 표2에 나타낸 바와 같이, 본 발명의 화합물을 적색 유기 전계 발광 소자의 발광층에 사용한 경우(실시예 49내지 60)가 종래 CBP를 적색 유기 전계 발광 소자의 발광층에 사용한 경우(비교예2)보다 효율 및 구동전압이 우수한 것을 확인할 수 있었다.As shown in Table 2, when the compound of the present invention was used for the light-emitting layer of the red organic electroluminescent device (Examples 49 to 60), compared with the case where the conventional CBP was used for the light-emitting layer of the red organic electroluminescent device (Comparative Example 2) It was confirmed that the efficiency and the driving voltage were excellent.
Claims (10)
[화학식 1]
상기 화학식 1에서,
Y1 내지 Y12는 각각 독립적으로 C(R1) 또는 N이고, 이때, Y1과 Y2, Y2와 Y3, Y3와 Y4, Y5와 Y6, Y6과 Y7, Y7과 Y8, Y9와 Y10, Y10과 Y11 및 Y11과 Y12 중 하나는 모두 C(R1)이되, 서로 결합하여 하기 화학식 2로 표시되는 축합 고리를 형성하고,
[화학식 2]
상기 화학식 2에서,
점선은 상기 화학식 1과 결합되는 부분이고,
상기 화학식 1 및 2에서,
X1 및 X2는 각각 독립적으로 N(Ar1), O, S, C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고, 이때, 적어도 하나는 N(Ar1)이며,
Y13 내지 Y16은 각각 독립적으로 C(R2) 또는 N이고,
Ar1 내지 Ar5는 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되며,
R1 및 R2는 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,
상기 Ar1 내지 Ar5, R1 및 R2의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있다.A compound represented by the following formula (1).
[Chemical Formula 1]
In Formula 1,
Y 1 to Y 12 are each independently C (R 1 ) or N, wherein Y 1 and Y 2 , Y 2 and Y 3 , Y 3 and Y 4 , Y 5 and Y 6 , Y 6 and Y 7 , Y 7 and Y 8 , Y 9 and Y 10 , Y 10 and Y 11, and Y 11 and Y 12 are both C (R 1 ), and are bonded to each other to form a condensed ring represented by the following formula (2)
(2)
In Formula 2,
The dotted line is a moiety bonded to the above formula (1)
In the above Formulas 1 and 2,
X 1 and X 2 are each independently selected from the group consisting of N (Ar 1 ), O, S, C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ) N (Ar < 1 >),
Y 13 to Y 16 are each independently C (R 2 ) or N,
Ar 1 to Ar 5 each independently represent a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms A C 6 to C 60 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 60 arylamine group, a C 3 to C 40 cycloalkyl group, a heterocyclic group having 3 to 40 nuclear atoms alkyl group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic of, C 6 ~ C 60 aryl phosphine group, C 6 ~ aryl phosphine of C 60 A pentacene group, a pin oxide group, and an arylsilyl group of C 6 to C 60 ,
R 1 and R 2 are each independently hydrogen, deuterium, a halogen, a cyano group, a nitro group, C 1 ~ alkynyl group of C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 of, C 3 ~ C 40 cycloalkyl group, the number of nuclear atoms of 3 to 40 of the heterocycloalkyl of the alkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, C 1 ~ alkyloxy group of C 40, C 6 ~ aryloxy group of C 60, C 1 ~ C 40 alkylsilyl group, C group 6 ~ C 60 aryl silyl, C 1 ~ group alkylboronic of C 40, C 6 ~ aryl boronic of C 60, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ selected from the group consisting of C 60 aryl amine, or a, combination adjacent groups may form a fused ring,
The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group and arylsilyl group of Ar 1 to Ar 5 , R 1 and R 2 , An alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group and an arylamine group are each independently a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkoxy group, group, C 3 ~ C 40 cycloalkyl group, the number of nuclear atoms of 3 to 40 hetero cycloalkyl, heteroaryl of C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 aryl group, C 1 ~ C 40 alkyloxy A C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, C 6 ~ C 60 aryl phosphine group of, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C to 1 or more substituents selected from the 60 group consisting of aryl amines may be unsubstituted or substituted have.
상기 화학식 1로 표시되는 화합물은 하기 화학식 3 내지 11로 표시되는 화합물로 이루어진 군에서 선택되는 화합물.
[화학식 3]
[화학식 4]
[화학식 5]
[화학식 6]
[화학식 7]
[화학식 8]
[화학식 9]
[화학식 10]
[화학식 11]
상기 화학식 3 내지 11에서,
X1, X2, R1 및 R2는 제1항에서 정의한 바와 동일하며, 이때, 복수의 R1은 서로 동일하거나 상이고, 복수의 R2는 서로 동일하거나 상이하다.The method according to claim 1,
Wherein the compound represented by the formula (1) is selected from the group consisting of compounds represented by the following formulas (3) to (11).
(3)
[Chemical Formula 4]
[Chemical Formula 5]
[Chemical Formula 6]
(7)
[Chemical Formula 8]
[Chemical Formula 9]
[Chemical formula 10]
(11)
In the above formulas 3 to 11,
X 1 , X 2 , R 1, and R 2 are the same as defined in claim 1 , wherein the plurality of R 1 s are the same or different from each other, and the plurality of R 2 s are the same as or different from each other.
상기 화학식 1로 표시되는 화합물은 하기 화학식 12 내지 20으로 표시되는 화합물로 이루어진 군에서 선택되는 화합물.
[화학식 12]
[화학식 13]
[화학식 14]
[화학식 15]
[화학식 16]
[화학식 17]
[화학식 18]
[화학식 19]
[화학식 20]
상기 화학식 12 내지 20에서,
Ar1, R1 및 R2는 제1항에서 정의한 바와 동일하며, 이때, 복수의 R1은 서로 동일하거나 상이고, 복수의 R2는 서로 동일하거나 상이하다.The method according to claim 1,
Wherein the compound represented by the formula (1) is selected from the group consisting of compounds represented by the following formulas (12) to (20).
[Chemical Formula 12]
[Chemical Formula 13]
[Chemical Formula 14]
[Chemical Formula 15]
[Chemical Formula 16]
[Chemical Formula 17]
[Chemical Formula 18]
[Chemical Formula 19]
[Chemical Formula 20]
In the above Formulas 12 to 20,
Ar 1, R 1 and R 2 are as defined in claim 1 , wherein a plurality of R 1 s are the same as or different from each other, and a plurality of R 2 s are the same as or different from each other;
상기 Ar1 내지 Ar5는 각각 독립적으로 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴아민기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되는 화합물. The method according to claim 1,
Wherein Ar 1 to Ar 5 are each independently C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, a C 6 ~ C 60 aryl amine groups and consisting of C 6 ~ C 60 aryl silyl group of ≪ / RTI >
상기 R1 및 R2은 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 화합물.The method according to claim 1,
R 1 and R 2 are each independently selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 6 to C 60 aryl, heteroaryl having 5 to 60 nuclear atoms, A C 6 to C 60 arylamine group.
Ar1, R1 및 R2 중 적어도 하나는 하기 화학식 21로 표시되는 치환기인 화합물.
[화학식 21]
상기 화학식 21에서,
L은 단일결합, C6~C40의 아릴렌기, 핵원자수 5 내지 40의 헤테로아릴렌기로 이루어진 군에서 선택되고,
Z1 내지 Z5는 각각 독립적으로 N 또는 C(R17)이고, 이때, 적어도 하나는 N이며,
R17은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 인접한 기와 결합하여 축합 고리를 형성할 수 있고,
상기 L의 아릴렌기, 헤테로아릴렌기와, 상기 R17의 알킬기, 알케닐기, 알키닐기, 시틀로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있다.The method according to claim 1,
And at least one of Ar 1 , R 1 and R 2 is a substituent represented by the following formula (21).
[Chemical Formula 21]
In Formula 21,
L is selected from the group consisting of a single bond, an arylene group having 6 to 40 carbon atoms, a heteroarylene group having 5 to 40 nuclear atoms,
Z 1 to Z 5 are each independently N or C (R 17 ), wherein at least one is N,
R 17 is hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 alkynyl, C 3 to C 40 cycloalkyl, nuclear atoms of 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, a nuclear atoms of 5 to 60 heteroaryl group, C 1 ~ alkyloxy group of C 40 of the, aryloxy of C 6 ~ C 60 , A C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine group , C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl group selected from the group consisting of an amine or of a, it is possible to bond the adjacent group to form a condensed ring,
The L-arylene group, heteroarylene group, wherein R 17 an alkyl group, an alkenyl group, an alkynyl group, an alkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group with siteul of, an aryloxy group, an alkylsilyl group, aryl silyl group, an alkyl boron group, an aryl boron group, an aryl phosphine group, aryl phosphine oxide group and an arylamine group, each independently, an alkenyl group of C 1 ~ C 40 alkyl group, C 2 ~ C 40 of, C 2 ~ C A C 3 to C 40 cycloalkyl group, a heterocyclic cycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkenyl group, C 6 -C 60 aryloxy groups, C 1 -C 40 alkylsilyl groups, C 6 -C 60 arylsilyl groups, C 1 -C 40 alkylboron groups, C 6 -C 60 the arylboronic group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide of the group and a C 6 ~ value to one or more of the substituents selected from the group consisting of C 60 arylamine Or it may be unsubstituted.
상기 화학식 21로 표시되는 치환기는 하기 화학식 A-1 내지 A-15로 표시되는 치환기로 이루어진 군에서 선택되는 화합물.
상기 화학식 A-1 내지 A-15 에서,
L 및 R17은 제6항에서 정의한 바와 동일하고, 이때, 복수의 R17은 서로 동일하거나 상이하며,
R21은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성할 수 있고,
상기 R21의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있으며,
n은 0 내지 4의 정수이다.The method according to claim 6,
Wherein the substituent represented by the formula (21) is selected from the group consisting of substituents represented by the following formulas (A-1) to (A-15).
In the above formulas A-1 to A-15,
L And R 17 is as defined in claim 6, at which time, a plurality of R 17 are the same or different from each other,
R 21 is selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 alkynyl, C 3 to C 40 cycloalkyl, aryloxy nuclear atoms 3 to 40 of the heterocycloalkyl of the alkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, C 6 ~ C 60, alkyloxy group of C 1 ~ C 40 , An arylamine group of C 6 to C 60 , a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine group , C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ selected from the group consisting of C 60 or aryl silyl, by combining groups of adjacent, may form a condensed ring,
Alkyl group of the R 21, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, an arylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, the arylphosphine oxide group and the arylamine group are each independently a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 3 to C 40 cycloalkyl group, alkyl, nuclear atoms of 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 of the heteroaryl group, C 1 ~ C 40 alkyloxy group of, C of 6 ~ C 60 aryl oxy group, C 1 ~ C 40 alkylsilyl group, C group 6 ~ C 60 aryl silyl, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic in, aryl of C 6 ~ C 60 phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl amines may be unsubstituted or substituted by one substituent at least one selected from the group consisting of,
n is an integer of 0 to 4;
상기 1층 이상의 유기물층 중에서 적어도 하나는 제1항 내지 제7항 중 어느 한 항에 기재된 화합물을 포함하는 유기 전계 발광 소자.1. An organic electroluminescent device comprising an anode, a cathode, and at least one organic material layer interposed between the anode and the cathode,
Wherein at least one of the one or more organic layers includes the compound according to any one of claims 1 to 7.
상기 화합물을 포함하는 유기물층은 정공 주입층, 정공 수송층, 전자수송층, 전자주입층 및 발광층으로 이루어진 군에서 선택되는 유기 전계 발광 소자.9. The method of claim 8,
Wherein the organic compound layer containing the compound is selected from the group consisting of a hole injecting layer, a hole transporting layer, an electron transporting layer, an electron injecting layer, and a light emitting layer.
상기 화합물을 포함하는 유기물층은 발광층이며,
상기 화합물은 상기 발광층의 인광 호스트인 유기 전계 발광 소자.10. The method of claim 9,
The organic compound layer containing the compound is a light emitting layer,
Wherein the compound is a phosphorescent host of the light emitting layer.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140025707A KR20150103968A (en) | 2014-03-04 | 2014-03-04 | Organic compounds and organic electro luminescence device comprising the same |
PCT/KR2015/002071 WO2015133808A1 (en) | 2014-03-04 | 2015-03-04 | Organic compound and organic electroluminescent device comprising same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140025707A KR20150103968A (en) | 2014-03-04 | 2014-03-04 | Organic compounds and organic electro luminescence device comprising the same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160110901A Division KR101813396B1 (en) | 2016-08-30 | 2016-08-30 | Organic compounds and organic electro luminescence device comprising the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150103968A true KR20150103968A (en) | 2015-09-14 |
Family
ID=54055551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140025707A KR20150103968A (en) | 2014-03-04 | 2014-03-04 | Organic compounds and organic electro luminescence device comprising the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20150103968A (en) |
WO (1) | WO2015133808A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020262865A1 (en) * | 2019-06-24 | 2020-12-30 | 덕산네오룩스 주식회사 | Compound for organic electric element, organic electric element using same, and electronic apparatus thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170019924A (en) * | 2015-08-13 | 2017-02-22 | 롬엔드하스전자재료코리아유한회사 | Organic Electroluminescent Compounds and Organic Electroluminescent Device Comprising the Same |
JP6498245B2 (en) * | 2016-08-19 | 2019-04-10 | 彩豐精技股▲分▼有限公司 | Compound and organic electronic device using the same |
CN113929691B (en) * | 2021-11-22 | 2024-02-02 | 烟台九目化学股份有限公司 | Compound containing oxazepinocarbazole structure and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110098293A (en) * | 2010-02-26 | 2011-09-01 | 다우어드밴스드디스플레이머티리얼 유한회사 | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
JP5415340B2 (en) * | 2010-03-31 | 2014-02-12 | ユー・ディー・シー アイルランド リミテッド | Organic electroluminescence device |
KR101559430B1 (en) * | 2012-02-22 | 2015-10-13 | 주식회사 엠비케이 | Organic light compound and organic light device using the same |
JP6025243B2 (en) * | 2012-05-10 | 2016-11-16 | 富士フイルム株式会社 | Photoelectric conversion device and imaging device using the same |
JP2014027041A (en) * | 2012-07-25 | 2014-02-06 | Fujifilm Corp | Organic material for deposition and organic photoelectric conversion element obtained by using the same, imaging element, deposition method, and method for manufacturing organic photoelectric conversion element |
-
2014
- 2014-03-04 KR KR1020140025707A patent/KR20150103968A/en active Search and Examination
-
2015
- 2015-03-04 WO PCT/KR2015/002071 patent/WO2015133808A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020262865A1 (en) * | 2019-06-24 | 2020-12-30 | 덕산네오룩스 주식회사 | Compound for organic electric element, organic electric element using same, and electronic apparatus thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2015133808A1 (en) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102487503B1 (en) | Organic compound and organic electroluminescent device using the same | |
KR101614599B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20150077220A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20180069475A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR101729372B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101571591B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101599597B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20180022189A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101571592B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101827067B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR102617611B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20180007097A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101641411B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101634852B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20150103968A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20150053027A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR101612160B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20160079546A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20160078102A (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20140064563A (en) | Organic compound and organic electroluminescent device comprising the same | |
KR102507368B1 (en) | Organic compound and organic electroluminescent device using the same | |
KR20150086107A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101813396B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR102642880B1 (en) | Organic compound and organic electroluminescent device using the same | |
KR101571590B1 (en) | Organic compounds and organic electro luminescence device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
AMND | Amendment |